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Background: Screening for cancer is a secondary prevention strategy that relies on early detection 
of disease. Screening is given to asymptomatic individuals who are at risk of developing cancer to 
identify and halt the pathological development of disease, reduce treatment invasiveness and 
improve outcomes. Perceived susceptibility (PS) – whether an individual feels they are personally 
vulnerable to a health-related condition or disease – has been shown to be associated with cancer 
screening uptake and past screening behaviour. 
Overall Objective: We propose to use data from Alberta’s Tomorrow Project (ATP) to address the 
research questions outlined below.  
Research Questions: Is PS to developing cancer associated with the incidence of mammography, 
prostate-specific antigen, sigmoidoscopy, and colonoscopy screening tests? Does an individual’s 
perceived susceptibility affect screening behaviour differently between tests? 
Methods: We included ATP participants between the ages of 35 to 70 years who reported being 
free of chronic conditions at their baseline survey and who had completed at least one follow-up 
survey. PS was measured using three variables: PS1-5 (measured on a 5-point scale from 1 [low 
risk] to 5 [high risk]): “Compared to other people your age, what do you think are your chances of 
being diagnosed with cancer in your lifetime”, PS100gen asked: “On a scale of 0% to 100%, what 
percentage of people your age in the general population do you think will be diagnosed with cancer 
in their lifetime?” and PS100my asked: “On a scale from 0% to 100%, on which 0 means you 
definitely will not be diagnosed with cancer and 100 means you definitely will be diagnosed with 
cancer, what would you estimate to be your chance of being diagnosed with cancer in your 




follow-up, we built a series of multivariable logistic regression models for each of the screening 
tests of interest, and adjusted for covariates such as age, education, family history, and marital 
status. 
Results: PS of developing cancer was statistically significantly associated with prostate-specific 
antigen (PSA) and sigmoidoscopy/colonoscopy screening behaviour over baseline and two waves 
of follow-up, spanning a total of 14 years, for both personal risk variables (PS1-5 and PS100my). 
Specifically, the odds of receiving compared to not receiving a PSA test were 1.36 times greater 
for a one-unit increase in PS1-5 (CI=1.07 – 1.72), and the odds were 1.02 times higher for a one-
unit increase in PS100my ranging from 0 to 100 (CI=1.01 – 1.03). Furthermore, the odds of 
receiving compared to not receiving a sigmoidoscopy/colonoscopy were 1.97 times greater for a 
one-unit increase in PS1-5 (CI=1.52 – 2.55), and the odds were 1.03 times greater for a one-unit 
increase in PS100my ranging from 0 to 100 (CI=1.0 – 1.04).  
Conclusion: Understanding how certain factors, such as PS, are associated with screening 
behaviour has been an important focus for addressing the underutilization of screening for cancer 
in Canada. Personal PS of developing cancer is predictive of screening behaviour for PSA and 
sigmoidoscopy/colonoscopy screening tests over time. These findings provide a basis for public 
health programming and policies throughout Canada, aimed at promoting screening behaviour. 
Future studies should explore additional factors, as outlined by existing social-cognitive models, 
such as perceived barriers to screening, to broaden the understanding these factors have in 
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Introduction and Overview 
1.0 Introduction 
Screening is a secondary prevention strategy that is usually directed at asymptomatic 
individuals with a high risk of disease. Screening relies on early detection to identify and halt the 
pathological development of disease.1,2,3 In Canada, the benefits of screening are regularly 
communicated to the public and screening services are free to access. However, screening 
continues to be an underutilized preventive health service.4,5 An important focus of research, 
specifically within the realm of health psychology and to public health practitioners, has been to 
study the role individuals play in contributing to their own health and well-being by adopting 
certain health behaviours, such as screening.6  
This thesis will explore whether perceived susceptibility (PS) – whether an individual feels 
they are personally vulnerable to a health-related condition or disease – a core component of the 
Health Belief Model (HBM), influences individual screening behaviours for a variety of cancers 
(breast, prostate, and colorectal cancer). Screening behaviour in this thesis is defined as whether 
or not individuals report undergoing any of the following tests: mammography, prostate-specific 
antigen (PSA), colonoscopy, and sigmoidoscopy.6,7,8,9,10 
1.1 Research Questions 
This study explored whether an individual’s perceived susceptibility to developing cancer 




sigmoidoscopy/colonoscopy screening tests; and whether an individual’s perceived susceptibility 
affects screening behaviour differently between tests. 
1.2 Hypotheses 
We hypothesize that persons between the ages of 35-70 years with greater levels of PS for 
developing cancer will be more likely to undergo screening tests over time. Furthermore, we 
hypothesize that the incidence of screening will differ among tests. 
To our knowledge, only one existing cross-sectional study11 examines PS and screening 
incidence across multiple cancer types and screening tests. Furthermore, only four out of 23 
previously conducted studies in this area of research were longitudinal in design, and all four only 
examined PS of breast cancer and incidence of mammography.11,12,13,14,15-29 Most previously 
published studies were cross-sectional, which prevents assessments of temporality, inhibiting our 
understanding of the direction of association between PS and screening behaviour. Furthermore, 
existing studies incorporated highly-select samples, limiting representation and generalization of 
study results. For example, Hassan et al.22 recruited individuals for their study primarily through 
posters and flyers distributed at a private tertiary hospital, which restricts enrollment to individuals 
who are at the hospital and see the prints. By using the ATP dataset, we can investigate the 
longitudinal association between PS and cancer screening for multiple diseases, and tests, while 
using a population-based sample.30  
In summary, this thesis used Alberta’s Tomorrow Project (ATP), a population-based cohort 
study, to answer our research questions. The data were explored descriptively using histograms 
for continuous variables and bar charts for categorical variables. Normally distributed continuous 
variables were summarized as means and standard deviations, non-normally-distributed 




and percentages.  To examine the association between PS and incident screening over the course 
of follow-up, we built a series of multivariable logistic regression models for each of the screening 
tests of interest, and adjusted for covariates such as age, education, family history, and marital 
status. Results revealed that personal PS of developing cancer was statistically significantly 
associated with mammography screening when analyzed cross-sectionally. While, personal PS 
was statistically significantly associated with prostate-specific antigen (PSA) and 
sigmoidoscopy/colonoscopy screening over baseline and two waves of follow-up, spanning a total 
of 14 years.  
These findings provide a basis for public health programming and policies throughout 
Canada, aimed at promoting screening behaviour, by fostering a better understanding for the 
associated role of PS of developing cancer to cancer screening health behaviour. More specifically, 
by highlighting personal PS to developing cancer for intervention-based targeted messaging in 
marketing campaigns, we may heighten an individual’s PS to developing cancer, enhancing their 











2.0 Study Rationale 
Standard screening practices for cancer include mammography, PSA,  sigmoidoscopy, and 
colonoscopy.31 The preventive and systematic application of screening tests can reduce disease-
associated morbidity and mortality.32,33 For example, breast cancer deaths can be reduced by 
approximately one-third in individuals who participate in regular screenings.34 Despite the 
existence of well-established screening guidelines and the widely communicated benefits of 
screening in Canada, screening is still underutilized.4,5 This underutilization points to the 
perplexing and multi-faceted question that continues to puzzle researchers: why is screening 
underutilized? 
One important area of study to help address this question is health psychology, which 
highlights the role of psychological and behavioural processes in health, illness, and healthcare.6 
By incorporating a health psychology lens and an established theoretical framework, we can 
explore the specific elements and processes of change in health behaviour, and begin to address 
the “why?”.10  
There are countless factors that may help explain individual differences in undertaking 
certain health behaviours, including socioeconomic status and demographic variables such as age 
and marital status.6,7 Some of these factors (e.g., age, sex) are not amenable to change and do not 
explain why similar individuals differ in terms of their propensity to perform certain health 
behaviours.6,7 This points to the role of cognitive factors, which may work with other variables to 
influence health behaviour. Specifically, the role of social cognition - how individuals make sense 




numerous research disciplines.6 A variety of social cognition models have been used to identify 
how cognitive factors, beliefs, and attitudes may play a more immediate and proximal role in 
influencing health behaviour.6,7,12 The role of these identified proximal factors are important as 
they are amenable to change, and may provide a grounds for health behaviour interventions.  
The Health Belief Model (HBM) is a cognitive model that is widely used today. This model 
comprises several core constructs, which are often examined additively to assess the likelihood of 
an individual performing a given behaviour (See Figure 1).7,13 One of the five core constructs is 
PS, which has been identified as one of the model’s most consistent predictors of behaviour.6,7 
This leads to the question being posed in this thesis: does PS have an independent influence on 
cancer screening behaviour? By controlling for a variety of known confounders and isolating PS, 
we can investigate the possible association that PS may have with specific cancer screening 
behaviours across multiple cancer screening tests, while contributing a piece to the complex puzzle 
surrounding “why?”.  
In order to assess this possible association between PS of developing cancer to cancer 
screening behaviour, we incorporated specific components of the HBM, which are shown in Figure 




Figure 1 The Health Belief Model (adapted from Conner and Norman, 20056) 
There are additional cognitive models that also measure perceived susceptibility, such as 
the Protection Motivation Theory.6 However, the data available for us to analyze in ATP, 
specifically the nature of the questions asked addressing PS, fit into the theoretical framework of 
the HBM.6,7 For example, Protection Motivation Theory often describes PS as perceived 
vulnerability, and posits that it is modified by an individual’s fear of acquiring a certain health 
threat (e.g., cancer).6 However, as ATP doesn’t measure fear of developing cancer, we wouldn’t 
be able to adjust for this intervening factor and would not be able to properly assess the relationship 
between PS of developing cancer to cancer screening behaviour. Furthermore, PS questions in 
ATP used similar language and phrasing to PS questions in the HBM (based on the scale by 
Champion, 198435), as they both assessed personal risk of acquiring a certain health threat (e.g., 
cancer) in the future.6,36 
To address the primary research questions, this thesis will involve a secondary analysis of 
Alberta’s Tomorrow Project (ATP) dataset, which is a longitudinal cohort of Albertan adults 




chronic disease. Bearing in mind the lack of longitudinal research specifically targeting the role of 
PS in influencing health behaviour (cancer screening), coupled with equivocal results from 
predominantly cross-sectional studies, this thesis can inform future research by examining the 
association between PS and screening in a longitudinal study design with a large sample size and 
a variety of questions that will allow for the collection of data on many potential confounders.30 
Specifically, exploring this research area using ATP data, we can examine the possible association 
between PS and incidence of cancer screening across multiple screening tests.30 With this in mind, 
this research - the sole identified longitudinal study with a population-based sample to assess the 
possible association between PS across multiple screening tests - can assist in broadening the 
understanding surrounding the possible role that PS plays in influencing screening behaviour.  
Data from five ATP questionnaires is used to address the research questions and hypotheses 
outlined in Section 1.1 and 1.2 above: the Health and Lifestyle Questionnaire (HLQ) (distributed 
to participants upon recruitment, which occurred in a rolling format between 2001-2009), Survey 
2004, Survey 2008, Update Health and Lifestyle Questionnaire (UHLQ), and Core Questionnaire 
(Core).30  
Results from this thesis can contribute to highlighting possible barriers and facilitators to 
cancer screening behaviour in Canada, while helping to inform public health initiatives by 
evaluating the role an individual's PS may play in influencing participation in cancer screening. 
Considering individuals within a given age bracket are more susceptible to certain types of cancer, 
according to research informed Canadian cancer screening guidelines37, they are more likely to be 
targeted via screening interventions. With this in mind, knowledge of PS to developing cancer can 
be harnessed by policymakers and public health practitioners to encourage further targeted 




cancer screening for mammography is most beneficial for women ages 50-69.37 With this in mind, 
by encouraging further targeted messaging surrounding the benefits of screening for breast cancer 
or the individuals’ personal risk of developing breast cancer, screening incidence may be improved 
in this group. Screening rates may also be improved for individuals in this high risk group by 
developing new means to target high risk individuals so perception of risk is in line with the reality 
of actual risk for developing breast cancer. Furthermore, this research can contribute to minimizing 
a knowledge gap by helping to address the unknowns regarding “why” people underutilize free, 
preventive, routine cancer screening tests when such tests have life-saving implications. 
2.1 Covariates 
A variety of factors may be associated with PS and cancer screening behaviour for 
mammography, PSA, and sigmoidoscopy/colonoscopy screening tests. With this in mind, a 
comprehensive list of covariates, including family history, education, income, age, marital status, 
employment status, and rural vs. urban residence, will be included in this study based on previously 











3.1 The Health Belief Model, Perceived Susceptibility and Cancer Screening 
PS may be associated with cancer screening uptake and past screening behaviour.14,38 PS, 
also referred to as perceived risk, is one of several theoretical components of the Health Belief 
Model (HBM), which was developed in the 1950s by Rosenstock, Hochbaum, and Kegels.39 PS 
has been identified as a key social-cognitive factor that may contribute to cancer screening 
behaviour across multiple types of cancers and screening techniques, while being influenced by a 
variety of individual differences including demographic variables, social pressure, and 
personality.6 Further evidence indicates that a higher PS of developing cancer is positively 
associated with the likelihood of participating or having participated in cancer screening practices 
for a variety of different cancers, including breast, prostate, and colorectal cancer.4,12-24,38,39 
The HBM serves as an explanatory and interventionist framework to address health 
behaviour and is based on the notion that one’s personal beliefs regarding a disease will be a key 
determinant of health behaviour. 7,8,9,12,14,38 For example, if a person believes they are likely to 
develop cancer, then they are more likely to get screened.9,15,25 However, the screening behaviour 
is predicated on two assumptions: 1) the motivation to act is based on the individual’s belief that 
screening for cancer will help reduce the chance of actually getting the disease; and 2) the benefits 
from screening, specifically in terms of risk reduction, outweigh the costs of actually getting 
screened for cancer.8,9 
The purpose of the HBM is not to provide a comprehensive explanation for all health-
related behaviours, but to identify key variables that may be identified as strong predictors of health 




disease before actively seeking preventive actions such as cancer screening.6,7,15,25 Specifically, the 
HBM highlights the association between an individual’s subjective state and health behaviour 
through a social-psychological lens.6,9 Health behaviour can be defined as an activity, such as 
cancer screening, which is undertaken by a person who perceives themselves as healthy to maintain 
health and to ultimately prevent disease or detect disease in an asymptomatic stage.8,40  
Components of the HBM, especially PS, have been empirically useful in their ability to 
predict health behaviour, specifically through personal use of preventative health services, 
including cancer screening.10,13,41Additionally, the HBM is supported by a rich history of literature 
documenting the implementation of this model as a theoretical framework for predicting and 
changing behaviour.10,25 The HBM is demonstrated to have a substantial effect on explaining PS 
of developing illness, compared to other models. HBM may better illustrate adherence and uptake 
of a health behaviour, while other models focus predominantly on the intention of adopting a health 
behaviour.10,25 For example, Lostao et al.16 explored whether women’s health beliefs and attitudes 
in Navarre, Northern Spain contributed to their participation in mass screening mammography, 
when compared to non-participants who served as the control group. Study and control groups 
were matched for education and occupational levels.16 Both study and control groups completed a 
questionnaire on attitudes toward health and illness.16 The authors found that participants were 
more likely to undergo mass mammography screening if they rated themselves as more susceptible 
to breast cancer (p<0.10), a finding that is consistent with Rosenstock’s updated 1974 HBM.16   
3.2 Literature Search 
A literature search was developed with the assistance of a health science librarian, 
incorporating systematic methods using Google Scholar and PubMed, which employed the 




[cancer screening OR early detection of cancer AND motivation OR uptake OR attendance OR 
attend OR participation OR participate OR participating OR non-participating AND “perception 
of health” OR “health perception” OR “perceived health” OR “health belief” OR health 
knowledge, attitude, practice OR “self-rated health” OR “self-assessed” OR “health attitude*” 
OR “perceived susceptibility”]. 
The search yielded 519 articles for title and abstract screening. After screening by title and 
abstract, 122 potentially relevant articles were selected for full-text screening. A total of 23 
relevant articles were identified at full text. Included articles were written in English, were 
quantitative in nature, included adults aged 18 years or over, and conducted primary or secondary 
analyses of human data. Furthermore, all 23 articles examined the relationship between 
individuals’ perceived susceptibility of developing breast, prostate, or colorectal cancer and their 
participation in associated screening programs. PS was measured differently in many studies 
(Table 1 Section 3.7), and all confidence intervals (CI) reported were at a 95% confidence level. 
3.3 Prostate Cancer 
One out of 23 peer-reviewed studies examined the potential association between an 
individual's PS to developing prostate cancer and prostate cancer screening through PSA. This 
cross-sectional study by Sweetman et al.42 was conducted in the United Kingdom and included 
participants (n=128) who were first-degree relatives (FDR) of prostate cancer patients diagnosed 
at age 65 years or less, within the last four years.42 Participants were mailed an information package 
including a self-administered questionnaire to complete, which highlighted the possible 
psychosocial and behavioural factors associated with PSA screening, including HBM constructs 




relationship between participants’ PS of developing prostate cancer to PSA screening behaviour, 
revealed a statistically significant positive association (p=0.001).42 
 However, results from this study by Sweetman et al. 42 should be interpreted with caution 
because they assessed the association between PS and PSA screening behaviour through the use 
of a univariate chi-square test, and therefore did not adjust for additional variables that may be 
associated with PSA screening behaviour. 42 Also, the participants were FDRs of individuals 
diagnosed recently (in the last four years) with PSA, and they may therefore be more aware of 
their heightened risk level of developing PSA. 42 With this in mind, we cannot be sure whether 
family history of PSA, additional confounders, or the selective nature of the sample were 
influencing the association between PS and PSA screening behaviour. 42  
3.4 Colorectal Cancer 
Seven out of 23 studies employed cross-sectional designs to assess whether PS to colorectal 
cancer may affect colonoscopy and sigmoidoscopy screening behaviour. All of these studies 
included participants between 34-70 years of age from Australia, China, Canada, United States, or 
England. 4,12-14,26,27,38 Six out of the seven studies found a statistically significant positive 
association between PS of developing colorectal cancer and incidence of colorectal cancer (CRC) 
screening.4,12-14,27,38 In contrast, one study reported an inverse association between perceived 
susceptibility of developing colorectal cancer and CRC screening.27 
Three of the seven cross-sectional studies measured screening behaviour of participants to 
understand and evaluate factors associated with CRC screening behaviour.12,27,38 Hughes et al.12 
and Dear et al.27 randomly selected participants via health-related databases, such as Regional 
West Health Services or University of Nebraska Medical Center12, and primary care physician 




Roll to enhance the reach of participant sampling. Palmer et al.38 conducted Random Digit Dialing 
(RDD) of individuals in Maryland. Comparable to the age demographic used in Hughes et al.12, 
Palmer et al.38 also included study participants from 50-75 years of age. 
Dear et al.27, recruited participants aged 55-74 years and invited them to participate in a 
colonoscopy screening test and study questionnaire. Dear et al.27 and Palmer et al.38 compared 
those who participated in screening to those who did not participate to understand factors 
associated with screening, including PS to developing CRC. Comparatively, Hughes et al.12 
included individuals who responded to a mailed questionnaire (n=393) that asked about reasons 
for participating in past screening behaviour, while comparing individuals from rural and urban 
dwellings. Interestingly, Hughes et al.12 and Palmer et al.38 yielded a statistically significant 
positive association between PS to developing CRC and screening behaviour (adjusted Odds Ratio 
[aOR]=3.72, CI=1.27 – 10.8812; aOR=3.08, CI=1.46 – 6.3738), while Dear et al.27 reported an 
inverse association between PS to developing CRC and screening behaviour, opposite of most 
findings (X2=30.02, p<0.001).12,27,38 However, uncontrolled confounding could be the cause of the 
inverse association in the Dear et al.27 study because the authors only assessed the association 
through univariate analyses.27 
 Three studies, by Mack et al.4, Madlensky et al.26, and Garcia et al.13, evaluated PS of 
developing CRC in persons with a first-degree relative (FDR) who had been previously diagnosed 
with CRC. Mack et al.4 contacted a sample of CRC patients from a population-based registry 
(n=640) and asked these individuals to identify their asymptomatic FDRs to complete an additional 
study survey, where 15% (n=55) of FDRs had been previously diagnosed with cancer, and 




seventy-six referred FDRs completed the study questionnaire to gauge potential predictors of 
screening behaviour.4  
Madlensky et al.26 assessed PS of developing CRC in FDRs of persons with CRC. FDRs 
who were over the age of 34 years and who did not have CRC completed a telephone interview 
and were included in the analysis.26 
Garcia et al.13 also recruited FDRs of CRC patients from a cohort of such patients listed on 
hospital or cancer registries (n=124), with additional participants recruited from a study assessing 
the accuracy of fecal immunochemical tests for CRC screening (n=210). A total of 334 FDRs were 
eligible to complete the study survey, which was administered in person prior to a 
gastroenterologist appointment.13 
Mack et al.4 and Garcia et al.13 examined predictors of screening in all respondents, while 
Madlensky et al.26 compared screeners to non-screeners. Screeners were participants who had 
received a past colonoscopy, sigmoidoscopy, or fecal occult blood test (FOBT), where reasons for 
the tests were based only on family history or routine, not PS of developing CRC. Comparatively, 
non-screeners were participants who had never underwent any of the above CRC screening tests.26 
Mack et al.4 and Garcia et al.13 found a statistically significant positive association for PS of 
developing CRC to having ever received a CRC screening test (aOR=1.18, CI=0.10 – 1.404; 
unadjusted Odds Ratio [uOR]=2.77, CI=1.25 – 6.1313), while Madlensky et al.26 did not find a 
statistically significant mean difference (p=0.42) between individuals’ perceived susceptibility of 
developing CRC. Due to the lack of statistical significance, Madlensky et al.26 did not include PS 
in the logistic regression model, and therefore did not assess the adjusted association between PS 




An additional cross-sectional study conducted by Leung et al.14 explored self-reported 
factors associated with the prevalence of CRC screening in Chinese community-dwelling 
individuals aged 60 years or older who demonstrated no personal history of cancer (n=251). The 
PS of developing CRC was not statistically significantly associated with participation in CRC 
screening (aOR=1.05, CI=0.68 – 1.63).14 
Despite the consistent results in support of a positive association between PS and CRC 
screening, the results must be interpreted with potential biases in mind. For example, Hughes et 
al.12 included a sample of predominantly married women, and this group has been shown to have 
higher than average levels of screening.15,16,19,24-26,43 
In addition, Hughes et al.12 may be limited by selection bias as eligible participants must 
have attended one of two participating health clinics. These attendance requirements could lead to 
selection bias because they create a sample of individuals who are more likely to get screened. 
With selection bias in mind, Mack et al.4 and Madlensky et al.26 only enrolled persons whose 
FDRs had CRC. Given the restrictive samples enrolled in these studies, the results may not readily 
be applicable to the average population, e.g., people of any age, race, and SES who live in the 
community. 
Furthermore, the approaches adopted by Dear et al.27 and Leung et al.14 demonstrated 
additional study limitations. Dear et al.27 provided participants in the screened group with in-
person assistance to complete the study questionnaires, while persons who did not get screened 
answered a condensed version of the questionnaires orally at home via telephone. Moreover, non-
screened participants may have been less incentivized to join the study because they received their 
condensed questionnaires 12 months after being initially invited to join the study.27 Furthermore, 




misclassification, where more accurate responses were reported in the screened group compared 
to the unscreened group. 
Leung et al.14 defined CRC screening as having any type of past CRC screening test done 
within the last ten years. As use of screening could differ depending on screening type (e.g., 
colonoscopy, sigmoidoscopy), it would be useful to explore the relationship between PS of 
developing CRC to each type of screening test separately, potentially through a subgroup 
analysis.14 With this in mind, non-stratified results may be overestimated as the relationship 
between exposure and outcome variables may differ depending on screening type. Furthermore, 
confounders including family history of CRC or any cancer, as well as the possession of health 
insurance were not reported, which could leave the results open to residual confounding.14 Finally, 
the study design included a small sample, which could lead to a lack of precision and limited 
statistical power to detect true effects.  
Furthermore, all seven studies are cross-sectional, thereby preventing the examination of 
temporality between PS and screening, a limitation impeding the ability to understand the extent 
to which PS is associated with screening behaviour, rather than vice versa. Given the cross- 
sectional nature of the data, we cannot estimate the incidence of screening by different levels of 
PS.  
3.5 Breast Cancer 
Fourteen out of 23 peer-reviewed studies assessed the association between perceived 
susceptibility, attitudes, and factors related to breast cancer and mammography screening 
behaviours.15-25,28,29,43 Similar to the findings for prostate and colorectal cancer, most of the studies 




variety of ways, specifically in regards to the study populations of interest, administered 
interventions, comparisons made, reported outcomes, and study timelines.  
3.5.1 Cross-sectional studies that compared attenders vs. non-attenders of past mammography 
screening 
Two cross-sectional studies conducted in Iran and Malaysia recruited women within the 
age range of persons who would be most likely to undergo mammography screening based on 
country-specific screening guidelines.18,22 Participants in both studies (n=41418, n=1,61922) 
completed in-person questionnaires to better understand predictors of mammography attendance, 
including cognitive motivators that were in-line with HBM.18,22 Both studies excluded persons 
with a previous breast cancer diagnosis or any other medical condition, along with persons who 
had communication barriers that could impede their ability to complete the study 
questionnaires.18,22 Both studies compared and contrasted reasons for receiving or not receiving a 
mammogram in the past using a cross-sectional study design, while assessing PS to developing 
breast cancer. Additionally, both studies reported a statistically significant positive association 
between PS of developing breast cancer and prior mammography participation.18,22 
The two aforementioned studies differed in regards to their methods of recruitment. 
Allahverdipour et al.18 recruited a specific population of Iranian women who attended five 
randomly selected urban health centres and two rural health centres on three weekdays over a two-
month period. Hassan et al.22 invited women to receive a mammogram at a private tertiary hospital 
in a suburban area of Malaysia, recruiting through the distribution of flyers and posters at the 
hospital, as well as through written articles in the media.  
Two other studies, Abu-Helalah et al.17 and Taylor et al.24, classified participants based on 




(n=353;24 n=44417), one time users (n=317;24 n=1917), or repeat users (n=516;24 n=4417). 
Specifically, Taylor et al.24 surveyed a large sample (n=1357) of women aged 50-75 years in four 
Washington State counties via telephone during mid-1989 to assess factors associated with repeat 
mammography use. Abu-Helalah et al.17 surveyed women (n=507) from 40-69 years of age who 
were randomly selected using a multistage cluster sampling technique throughout six randomly 
selected regions of Jordan. Both Abu-Helalah et al.17 and Taylor et al.24 had participants complete 
a questionnaire that incorporated the HBM as the conceptual framework for analysis and compared 
women with varying mammography experiences.24 Taylor et al.24, reported that a high personal 
belief of susceptibility to breast cancer (aOR=0.85, CI=0.45 – 1.62) and a minimum 10% lifetime 
risk of developing breast cancer (aOR=0.69, CI=0.49 – 0.97) were independently associated with 
repeat vs. onetime use of mammography screening. Furthermore, individuals who never had a 
mammogram in the last five years (7%) perceived themselves to be at a lower risk of developing 
breast cancer compared to onetime (8%) and repeat users (14%).24       
Abu-Helalah et al.17 reported that as PS decreased, so too did the frequency of screening 
attendance. Specifically, 44.8% (the highest percentage) of participants who agreed/strongly 
agreed with the statement “I think I have a low risk of breast cancer, and therefore, I do not need 
to undergo mammography screening” never underwent screening.17 Comparatively, as screening 
frequency increased, agreement with the low risk statement decreased.17 For example, people who 
had been screened via mammography agreed/strongly agreed less often to the low PS statement 
(20%) than those who had never been screened (44.8%), which further decreased (13.9%) in 
participants who regularly underwent screening (p<0.0001).17 
An additional cross-sectional study conducted in Pennsylvania by Lerman et al.15, 




(n=900). Participants were divided equally and allocated to either the case or control group. The 
case group consisted of women (n=450) randomly selected from the member list of the Health 
Maintenance Organization (HMO) of Pennsylvania and New Jersey, while the control group 
(n=450) included age-eligible women from the same region, but not from the HMO.15 All 
participants received a brief 10-minute telephone questionnaire by trained interviewers to assess 
factors that may contribute to adherence to breast cancer screening.15 Women who attended 
mammography screenings in the past were more likely to perceive themselves at a greater risk of 
developing breast cancer compared to women who did not attend mammography screening.15 
Furthermore, reported results revealed that PS was an independent predictor of repeat 
mammography use (aOR=1.8, CI=1.10 – 2.80).15 
Lastly, a study by Holm et al.43 also examined past mammography screening behaviour 
using a small convenience sample (n=97) of women aged 38-84 years. Holm et al.43 compared PS 
to developing breast cancer to ever having received a mammogram, time since last mammogram, 
and frequency of mammograms. After calculating means, standard deviations, and correlations of 
PS to ever having received a mammogram, Holm et al.43 did not report a statistically significant 
association using t-test analyses (p=1.00). 
Despite the range of study populations and varying sample sizes, recruitment methods, 
study durations and sample characteristics, five out of six cross-sectional studies that explored the 
relationship between PS and past mammography screening behaviour found a statistically 
significant positive association between exposure and outcome.15,17,18,22,24 All studies encompassed 
a variety of notable limitations, reducing confidence in the results, that should modulate the 
interpretation of results. Allahverdipour et al.18 and Hassan et al.22 may have employed recruitment 




centres and two out of six rural health centres to recruit participants, limiting the study sample to 
women who attended these specific health centres. This sampling methodology was narrowed 
further by enrolling participants within a limited and select window of time throughout three days 
of the week over a two-month period.18 This non-random, narrowed time frame for recruiting 
participants permitted only select individuals to be enrolled in the study, and included individuals 
who were seeking health care for any reason. This ‘seeking’ behaviour has been shown to be 
associated with screening behaviour.18 With this in mind, recruitment bias is probable and may 
have generated a sample population that overrepresented women who were more likely to seek 
screening behaviour.  
Hassan et al.’s22 study may have been biased because of the limited recruitment methods 
used to enroll participants. The authors distributed posters and flyers at one private tertiary hospital 
in Malaysia, along with articles that were printed in local media.22 This recruitment method is 
limiting in that participation is restricted to individuals who are at the hospital and see the prints, 
or individuals who have access to distributed media articles. Additionally, similar to the study by 
Allahverdipour et al.,18 this recruitment method promotes the recruitment of women who are 
visiting the hospital, and are therefore already displaying health seeking behaviour.18,22 
3.5.2 Cross-sectional studies that compared attenders vs. non-attenders of current 
mammography screening 
Four additional cross-sectional studies conducted in Spain, Finland, Israel and the United 
States recruited women within the recommended screening age brackets to examine the role of 
perceived susceptibility of developing breast cancer to current, one-time mammography screening 
behaviour.16,19,28,29 All three studies invited participants to attend mammography screening and 




Specifically, Lostao et al.16 invited participants aged 45-60 years who were already enrolled in an 
early detection breast cancer program (n=708) to receive a mammogram and complete a self-
administered questionnaire after the screening test. People who did not get screened completed the 
questionnaire from home. Lostao et al.16 reported a statistically significant positive association 
between PS of developing breast cancer and participation in mammography screening tests 
(p<0.05). 
Comparatively, Aro et al.19 assessed psychosocial predictors of attendance for an organized 
breast cancer screening program in a large population of 50 year-old Finnish women (n=1,587) 
who were invited to attend their first mammogram screening.19 Multivariable stepwise logistic 
regression did not reveal a statistically significant positive association between PS of developing 
breast cancer to mammography screening attendance (aOR=1.20, CI=0.99 – 1.47).19 
 Champion28 also examined differences between compliant and noncompliant attenders of 
mammography screening (n=404), including PS to developing breast cancer and likelihood of 
pursuing mammography screening in women over 40, selected via random digit dialing.28 Women 
who participated in the study completed a baseline questionnaire which assessed PS and past 
mammography usage.28 About six weeks after the baseline questionnaire was completed, an in-
home interview was conducted, which also incorporated an intervention-based teaching session 
designed to increase mammography usage.28,44 Immediately following this interview, attitudes 
were assessed, which included PS and mammography screening behaviour.28 Finally, one-year 
after the intervention, an additional interview was conducted to measure HBM beliefs, such as PS, 
as well as mammography screening behaviour.28 Not surprisingly, as all women received the 
intervention, the majority of participants were compliant mammography users (n=286 compliant 




to mammography uptake in compliers and non-compliers and the result was not statistically 
significant (p=0.16).28  
Azaiza and Cohen29 conducted a cross-sectional study of Arab women (n=568) between 
20-60 years of age. Women were placed in subgroups classified by religious denomination 
(Muslim, Christian, Druze) to identify differences in health beliefs depending on religious 
affiliation.29 A telephone questionnaire was completed by all participants to evaluate the 
relationship between PS and mammography screening according to religious affiliation (Druze; 
n=104, Muslim; n=305, or Christian; n=159), which did not yield statistically significant mean 
differences across groups, calculated by univariate analysis of variance.29 Simple logistic 
regression was conducted (combining all participants regardless of religious denomination), which 
also did not yield a statistically significant association (uOR=0.56, CI=0.29 – 1.06).29 
Several study limitations were noted in all of the cross-sectional studies that compared PS 
of developing breast cancer to mammography use. Aro et al.19, invited a select group of 50 year-
old Finnish women who were due for their first mammogram. With a specific and limited 
population from which to sample based on the designated enrollment criteria, results can only be 
applied to this specific group, limiting the generalizability of study results. 
Champion’s28 study may have been affected by selection factors because participants were 
already exposed to a prior screening intervention. Specifically, the previous intervention was 
geared at increasing screening uptake, and this predisposes participants to being screened, which 
could ultimately overestimate the association between PS of developing breast cancer and 
screening via mammography.28 Furthermore, participants were predominantly middle class 




3.5.3 Longitudinal retrospective cohort study design 
One out of 15 breast cancer studies was a longitudinal retrospective cohort study design 
and was conducted by Cockburn et al.21. Participants (n=180), women from 50-69 years of age, 
completed telephone interviews to assess factors that predicted attendance for mammography 
screening at a relocatable screening service in rural Victoria, Australia. Three months prior to the 
service becoming available in the area, a recruitment campaign took place via methods such as 
local media announcements and displays.21 Two weeks prior to the screening service becoming 
available in the area, telephone interviews were conducted with study participants.21 Upon 
attending the screening test, which was operating for a 10-week period, women were matched to 
their interview responses by telephone number and year of birth.21 Each variable, including PS of 
developing breast cancer, was independently tested for an association with mammography 
attendance.21 Results indicated that, when compared with persons who did not attend 
mammography screening, women who attended screening perceived themselves at some risk of 
developing breast cancer in the future (aOR=2.73, CI=1.07 – 6.99).21 
Similar to the aforementioned cross-sectional studies, Cockburn et al.’s21 study has 
potential issues with bias. Specifically, with telephone interviews assessing PS being conducted 
during the recruitment campaign, encouraging attendance and providing awareness for the 
relocatable mammography screening service, participants may have been made more cognizant 
of their risk of developing mammography prior to their telephone interview.21 Additionally, 
participants may have been affected by a social desirability bias stemming from frequent 
exposure to recruitment material prior and/or during their telephone interview.21 This bias could 
overestimate the study results by persuading the individual’s responses to questions during their 
interview, to responses they think will be well received by others.45 Moreover, as sampling was 




and 9 pm on weekdays and weekends, there was a limited window of opportunity for people to 
be enrolled in the study, which may have restricted the sample to individuals who answered their 
phones within these specified times.21 Finally, the study incorporated a small sample size 
(n=180), which may have limited the study's power to detect differences between attenders and 
non-attenders.21  
3.5.4 Longitudinal prospective cohort studies 
Three out of 14 breast cancer studies were prospective in nature and incorporated a 
longitudinal study design.20,23,25 Two of these three studies yielded statistically significant results 
when examining perceived susceptibility of developing breast cancer to mammography 
screening.20,23 All three studies differed in regards to recruitment methods, follow-up periods, 
comparison groups, and participant age brackets. All three studies had a low response rate, and 
two studies reported excluding individuals with a history of breast cancer at baseline. 
To expand, Chamot et al.20 invited 4,000 women ages 50-69 years in Geneva, Switzerland 
who had not been screened within the past two years to join a prospective study that compared 
women who participated in either organized or opportunistic screening for breast cancer, to women 
who had not participated in any breast cancer screening. This study also examined the determinants 
of screening behaviour, which included risk perception for developing breast cancer compared to 
other women in the same age group at baseline and at follow-up.20 The women were invited to 
participate in the study and subsequently 2,244 completed a baseline questionnaire. Within the 
eight-month span of following participants (beginning from their invitation to be screened), a 
follow-up questionnaire was sent to participants eligible for a mammogram within the study period 
(n=1,419) and 932 responded. Individuals were excluded from the study if they had high familial 




having a higher risk perception was independently associated with mammography attendance 
(aOR=1.8, CI=0.89 – 3.60).20 
Sutton et al.23 conducted a prospective study with female participants from 50-64 years of 
age (n=1,301) who were due to be contacted for their first mammogram in inner city London, 
England. Women were randomly drawn from a pool of 24 general practitioners and 11 practices 
in four inner-city boroughs. Prior to receiving a mammography screening invitation, women were 
interviewed in their homes or sent a questionnaire via mail.23 Additionally, a further control group 
was incorporated that comprised individuals who were not interviewed in their homes or sent a 
questionnaire via mail to assess the effect of being interviewed on attendance. Similar to other 
studies discussed above, participants were primarily white and married. Unadjusted univariate 
logistic regression reported PS as a significant predictor of mammography attendance (uOR=1.39, 
CI=1.16 – 1.66).23 
Lastly, Manjer et al.25 conducted a population-based prospective cohort study that recruited 
women living in Malmo, Sweden between 1991 and 1996 (n=17,035) and followed them over 
several time points, including a re-examination that took place 16 years after initial recruitment 
(n=3,045). Individuals who completed the re-examination up to September 2010, and who had 
also completed prior baseline questionnaires, were invited to participate in the present study 
(n=1,554) to investigate attitudes, social networks, and social relations in women who both 
attended and did not attend mammography screening.25 Women were aged 61-84 years at re-
examination.25 Manjer et al.25 assessed both exposure and outcome variables in the past and did 
not report a statistically significant relationship at follow-up for PS of developing breast cancer to 




Several limiting factors should be noted in the aforementioned studies. One common 
limitation among all three studies was the issue of bias due to exclusion criteria, loss to follow-up, 
and non-response.20,23,25 Specifically, the remaining portion of the samples may not embody 
characteristics that accurately reflect the target population. For example, Sutton et al.23 had a 
sample dominated by married women, which is a characteristic that has been shown to be 
positively associated with attendance for mammography.15,16,19,24,25,43 Lastly, the study by Manjer 
et al.25 was further limited at re-examination with an additional loss to non-response, but also a 
loss of participants from death, likely due to the 16-year follow-up since baseline. Ultimately, all 
three studies incorporated potential systematic errors into their study designs, thereby leading to 
the possibility of bias that could overestimate the association between PS and screening 
behaviour.20,23,25 
3.6 Multiple types of cancer 
One out of 23 studies assessed PS of developing breast cancer and colon cancer to 
screening behaviour via mammography and sigmoidoscopy/colonoscopy screening tests.11 
Helzlsouer et al.11 conducted a cross-sectional study of employees from the Johns Hopkins 
Oncology Center to examine perceived susceptibility and compliance with screening behaviour. 
Participants (n=509) completed questionnaires about their perceived susceptibility of developing 
cancer, as well as their employment environment, job type, and exposure to carcinogens.11 No 
association between PS and adherence to preventative health screening was observed for any of 
the screening tests.11  
Helzlsouer et al’s.11 sample of individuals was not representative of the general population. 
The authors included employees of an oncology center who could be presumably more aware and 




possible overrepresentation of employees with good health practices, ultimately over representing 
people who get screened.11 More specifically, regardless of their PS to developing cancer, 
employees of an oncology center would be more likely to have a heightened awareness 
surrounding the importance of screening  behaviour, and be more apt to get screened for cancer.  
3.7 Overall Summary 
In summary, although the majority of existing literature suggests a link between perceived 
susceptibility of developing cancer and cancer screening, the existing body of evidence is limited 
by a predominance of cross-sectional studies, studies with limited generalizability, and studies 
(with one exception) that focus on a single cancer and a single screening approach. To better assess 
predictors of screening behaviour and to best identify behaviours related to preventive health 
practices, a comprehensive study design that examines several screening behaviours over time is 
important as we have no evidence to assume that behaviour is consistent across different screening 
tests or time points in the same population. Furthermore, a study with a large sample that is 
randomly recruited from the general population would be beneficial to evaluate the association 
between perceived susceptibility and cancer screening behaviours. Specifically, population-based 
studies like ATP incorporate a representative sample, increasing the probability of conducting 
unbiased analyses of the association between the exposure and outcome variable.46 Furthermore, 
a population-based sample creates data that can be applied to the ‘average’ individual, which is 
necessary for informing the development of related policies, such as screening recommendations 
and guidelines.  Existing studies appear to incorporate highly-select populations, limiting the 
ability to make inferences for the average person regarding PS of developing cancer to incidence 
of cancer screening. Therefore, existing studies impede the understanding of how the potential 




The data compiled in Alberta’s Tomorrow Project (ATP), which utilizes a longitudinal, 
population-based sample and assesses multiple types of cancer screening tests, will help to address 
the aforementioned knowledge gaps in the published literature.30 Additionally, ATP includes a 
variety of demographic variables that have been shown to affect screening behaviour.30 For 
example, out of 23 studies described above, 20 studies assessed the relationship between education 
and screening behaviour. Furthermore, 11 studies assessed the relationship between income and 
screening behaviour, 17 studies assessed age and screening behaviour, and 13 assessed family 
history of cancer to screening behaviour (refer to Table 2 in the Section 4.5 of the methodology 
for a complete list of covariates and the associated references). By collecting data on these 
covariates, along with data on other covariates that have been previously assessed in the published 
literature, such as urban vs. rural place of residence, work status, and marital status, we can better 
control for confounding factors and establish a stronger evidence base from which to evaluate the 
link between perceived susceptibility of developing cancer and incidence of screening behaviour.  
 
Table 1 Measurement of Perceived Susceptibility for Literature Review Studies  
Study Authors Year How PS Data were 
Collected 
Measurement for PS 
Abu-Helalah et al.17 2015 • Structured interview based 
on literature review  
• Delivered through face-to-
face interviews 
• Asked: "I think I have a low risk of breast 
cancer, and therefore do not need to undergo 
mammography screening" 
• 5-point Likert scale (strongly agree to 
strongly disagree) 
Allahverdipour et al.18 2011 • Self-administered 
questionnaire  
• Champion's revised HBM 
scale 
• 5-point Likert scale (strongly disagree to 
strongly agree) 
Aro et al.19 1999 • Postal questionnaire  • Measured perceived breast cancer risk 
with 4-point Likert scale (low, moderate, 
high, don’t know) 
Azaiza and Cohen29 2006 • Telephone survey  
• HBM questions adapted 
from  Champion's HBM 
• Used two items eliciting self-PS from  a)  
1=very low chance, to 5=a very high chance 
and b) self-susceptibility in relation to the 
general population; 1= much lower than the 
general population, to 5, much higher than 




Study Authors Year How PS Data were 
Collected 
Measurement for PS 
Chamot et al.20 2007 • Postal questionnaire  • Question about perceived risk compared to 
women in the same age group (lower, 
similar, higher, no opinion) 
Champion, V.28 1994 • Postal questionnaire  • 5-point Likert scale from 1 (strongly 
agree) to 5 (strongly disagree) 
• 5 items measuring self-perceived risk, 
such as " I am likely to get breast cancer in 
the future" 
Cockburn et al.21 1997 • Telephone interview  • Perception of risk for breast cancer  
• Choice of either: none at all or at least 
slight 
Dear et al.27 2008 • Self-administered 
questionnaire on study site 
(participants) 
• Telephone questionnaire 
(non-participants) 
• Agreed to participate, 
completed 15 page 
questionnaire, didn't agree to 
participate completed a 2-
page questionnaire  
• Questions asking; 
1. "What is your risk of colon cancer over 
your whole life?", with choice from, 1 in 10, 
1 in 25, 1 in 75, 1 in 100, 1 in 150, 1 in 250, 
1 in 350, 1 in 500, and 1 in 1000 or less. 
2. "What is your risk of colon cancer in the 
next 5 years" 
with the same choices as above, and 
3. "If you get colon cancer, what if your 
chance of dying from it?", with the choices 
of 10%, 25%, 33%, 50%, 66%, 75%, and 
100%.  
Garcia et al.13 2011 • In-person interview • Question asking participants about risk 
compared to general population (higher, 
same, lower)  
Hassan et al.22 2015 • Self-administered 
questionnaire  
• Cited perception that they are not at risk  
(yes/no) 
Helzlsouer el al.11 1994 • Self-administered survey 
and brief written 
questionnaire and a 
computer-based questionnaire  
• Participants were asked to estimate their 
absolute risk of developing cancer in the 
next 20 years or the next 40 years as a 
percentage from 0% to 100%. 
Holm et al.43 1999 • Postal questionnaire  • Health Belief Model instrument developed 
by Champion46 
• HBM variables measured in a 31 question 
Likert scale with a choice of response from 
1 (strongly disagree) to 5 (strongly agree)  
Hughes et al.12 2015 • Postal questionnaire • Developed own questionnaire (43 
questions)  based on HBM constructs 
• 5-point Likert scale from with choices 
from strongly disagree to strongly agree 
Lerman et al.15 1990 • Telephone survey using a 
brief structured questionnaire  
• Forced choice 
• 4-point scale, options; 1 in 5, 1 in 10, 1 in 
25, or 1 in 50 chance of getting breast 
cancer  
Leung et al.14 2016 • Questionnaire administered 
by trained student helpers 
• Chinese version of the 35-item CRC 
Perceptions and Screening Instrument 
(CRCPS).47,48 
• 5-point Likert scale (strong disagree to 
strongly agree), higher scored indicated a 
greater PS.  
Lostao et al.16 2001 • Self-administered, 
structured questionnaire  
• Health Attitude Scale49,50 




Study Authors Year How PS Data were 
Collected 
Measurement for PS 
great" or "there is a great possibility that I 
will develop breast cancer" 
• 5-point Likert scale from strongly disagree 
to strongly agree 
Mack et al.4 2009 • Postal questionnaire • Self-developed questionnaire based on 
modification of a prior Alberta general 
population 
• 5-point Likert scale from strongly agree to 
strongly disagree 
• PS assessed through questions; 
1. "The chance I may develop CRC is high" 
and 2. "Compared to others my age, I am at 
a lower risk of CRC 
Madlensky et al.26 2003 • Telephone interview  • Scales assessing PS were  scored using a 
7-point Likert scale, and added together, and 
were developed by researchers at the 
Indiana University School of Nursing. 
Manjer et al.25 2015 • Self-administered 
questionnaire 
• "Self-rated risk for getting breast cancer" 
(low/medium/high)  
Palmer et al.38 2011 • Telephone interview  • 80 item survey overall 
• PS consisted of three items modified from 
Lipkus51  
• Participants were asked about their 
lifetime risk, comparison of personal risk 
with peers, and level of concern participant's 
had for developing CRC 
• Measured on a 4-point Likert scale  
Sutton et al.23 1994 • In-home interview or postal 
questionnaire  
• 5-point scale completed in presence of 
interviewer (multi-item) 
Sweetman et al.42 2006 • Self-administered 
questionnaire 
• Asked: “What do you think your risk is 
compared with the average man your age?”  
• 5-point Likert scale (very much lower than 
average to very much higher than average) 








 4.1 Alberta’s Tomorrow Project Data Set 
ATP is a population-based longitudinal cohort study that was launched in October 2000 as 
a research initiative by the Alberta Cancer Board, Division of Population Health and Information, 
to study the etiology of cancer and other chronic diseases.30 Eligible participants recruited for the 
study included males and females aged 35-69 years who intended to live in Alberta for at least one 
year, who had no personal history of cancer other than non-melanoma skin cancer at baseline, and 
who were able to complete self-reported written questionnaires in English.30,53,54  
Participant enrollment occurred from 2000 to 2008 and incorporated a two-stage sampling 
design.53,54 As approximately 97% of Albertans within the targeted sampling frame had a landline, 
random digit dialing (RDD) was conducted by an experienced social research group at the 
University of Alberta.53 Stage one identified eligible individuals from 17 regional health 
authorities in Alberta in the year 2000, and was followed in stage two by selecting one eligible 
adult in each household.53  
Following recruitment, eligible adults were mailed a consent form and the Health and 
Lifestyle Questionnaire (HLQ) (n=31,212), the first administered survey containing questions 
addressing cancer screening tests, personal and family health history, reproductive health, 
smoking, sun exposure, spirituality, social support and stress, body measurements and 
demographic characteristics.30,53 Participants were also invited to provide their health insurance 
numbers to allow for linkage to health administrative databases.53  
Follow-up surveys about health and lifestyle characteristics were administered in 2004 and 




Survey 2008 (n=20,801) was administered to participants who joined ATP between 2000-2007.30 
Thus, participants who were recruited between 2000-2003 received follow-up Survey 2004 and 
Survey 2008, while participants recruited later only received Survey 2008. All participants, 
regardless of recruitment date, completed the baseline HLQ.30 
In 2008, ATP became one of five regional cohorts to join the Canadian Partnership for 
Tomorrow Project (CPTP).30,53 ATP participants who joined the CTPT completed the Update: 
Health and Lifestyle Questionnaire (UHLQ) or Core Questionnaire, which are also included in the 
analyses for this study.30,53 
In ATP, PS questions were only asked in Survey 2004. To establish a baseline for the 
analyses in this thesis, we merged participants’ responses to the HLQ and Survey 2004 and formed 
a combined baseline straddling both time points. Variables drawn from HLQ included sample 
characteristics such as age, sex, marital status, education, etc. Responses to the screening questions 
at HLQ and Survey 2004 were merged to form baseline questions pertaining to whether 
participants were ‘ever screened’ for each of the cancers of interest in this thesis. 




4.2 Eligibility Criteria 
For the purpose of this study, ATP male or female participants of any age between 35-70 
years who reported being free of cancer at baseline and who had at least one follow-up interview 
after Survey 2004 were included in our analyses.   
To determine if participants were free of cancer at baseline, we examined a subset of 
questions from the HLQ and Survey 2004. Specifically, from the HLQ, if participants were free of 
cancer at baseline they responded ‘no’ to the question asking participants if a doctor ever told them 
they had cancer other than non-melanoma skin cancer.  
Similarly, a question in Survey 2004, asked participants to identify since joining the study 
if a doctor has ever told them they have cancer other than non-melanoma skin cancer (yes/no). If 
participants responded ‘yes’ to either question from HLQ or Survey 2004, they were not free of 
cancer at baseline, and therefore, were not eligible for this study. 
Lastly, participants who were eligible for this study must have completed Survey 2004, the 
baseline survey for this study, as this survey contained the questions measuring PS.   
4.3 Exposure Variable 
To measure the exposure variable (PS) from ATP data, Survey 2004 was used.  
Three questions from Survey 2004 measured an individual’s perceived susceptibility to developing 
cancer. The first question asked participants: “Compared to other people your age, what do you 
think are your chances of being diagnosed with cancer during your lifetime? (Do not include skin 
cancer, other than melanoma)”. As responses went on a 5-point Likert scale ranging from 1 (“I am 
at a much less risk than others”) to 5 (“I am at a much higher risk than others”), this thesis will 
refer to this question as PS1-5. Furthermore, PS1-5 was treated as an ordinal, continuous variable 




PS questions asked participants to use a percentage value between 0% to 100% when they 
responded to the following questions: question two, “On a scale of 0% to 100%, what percentage 
of people your age in the general population do you think will be diagnosed with cancer in their 
lifetime?”; and question three, “On a scale from 0% to 100%, on which 0 means you definitely 
will not be diagnosed with cancer and 100 means you definitely will be diagnosed with cancer, 
what would you estimate to be your chance of being diagnosed with cancer in your lifetime”. Both 
questions two and three are continuous and measure PS on a scale from 0% to 100%, but differ in 
terms of how they direct the PS question. Specifically, question two asks participants about the 
general population risk of developing cancer, and will be referred to as PS100gen in this thesis, 
while question three asks participants about their personal PS to developing cancer, and therefore 
will be referred to as PS100my in this thesis. For the purpose of analyses, both PS100gen and 
PS100my will be interpreted on a scale from 0 to 100. See Table 1 in Section 3.7 above to find a 
complete list showing how all 23 studies collected data and measured PS. 
4.4 Outcome Variable 
We used self-report questions from HLQ and Survey 2004 to assess screening behaviour 
for mammography, PSA, and sigmoidoscopy/colonoscopy tests at baseline.  
Questions in the HLQ concerning colorectal screening using sigmoidoscopy/colonoscopy 
screening tests were adapted from the 2000/01 Canadian Community Health Survey (CCHS)55 and 
the California Health Interview Survey 2001 and were used to assess CRC screening incidence.53 
In the HLQ, participants were asked, “Have you ever had a sigmoidoscopy or colonoscopy 
exam?”, followed by a brief description of the procedure.54 Participants could then choose 1 of 3 




Questions in the HLQ regarding PSA, and mammography screening tests originated from 
the CCHS and followed the same aforementioned question format.53,54,57 This information from 
the HLQ was used to supplement Survey 2004 as baseline data for this particular study, as HLQ 
addressed screening behaviour prior to commencing participation in ATP. As previously 
discussed, Survey 2004 captured data surrounding the exposure variable of interest (PS), but 
provided screening behaviour information “since joining the study”. For example, Survey 2004 
asked “Since you joined the study, have you had a colonoscopy”, where participants could 
respond: a) yes, and the specific year they received the colonoscopy; b) No; or c) Don’t know. 
Additional questionnaires that were used as “follow-up” surveys for this study included Survey 
2008, which was administered between 2008 to 2009 and CORE from the CPTP, which was 
distributed from 2011-2015 (see Figure 2). Both questionnaires addressed cancer screening for 
mammography, PSA, and colonoscopy/sigmoidoscopy in a similar format to HLQ and Survey 
2004.30 
4.5 Covariates 
There are a variety of factors that may be associated with PS and cancer screening 
behaviour for mammography, PSA, and sigmoidoscopy/colonoscopy screening tests. These 
potential confounders include sociodemographic characteristics such as education, age, and work 
status.11-15,25-29 In addition, family history of cancer, and place of residence (rural vs. urban), have 
also been previously identified by at least one study as being associated with past screening 
behaviour. The effect of these covariates may be consistent or differ across types of screening. For 
example, age and family history have been assessed across all screening tests, while rural vs. urban 
residence has been assessed with mammography and sigmoidoscopy/colonoscopy screening, but 




be included in the data analysis, as well as the corresponding studies from the literature review 
that reported these covariates as confounders. In addition to being assessed in previously published 
literature, these variables should be considered in our study because of their underlining theoretical 
influence on PS and/or screening behaviour. Specifically, the HBM model (depicted in Figure 1 
Section 2.0) posits that demographic variables, such as age and marital status, are related in some 
way to both PS and screening behaviour.  For example, an individual who is married may be more 
likely to perform a health behaviour, such as cancer screening, because they feel a sense of 
responsibility for others and ultimately an obligation to exhibit healthy behaviours.58 
Comparatively, an individual with a family history of cancer may have had more exposure to the 
disease itself and may be more aware of their own heightened risk, influencing their PS of 
developing cancer.59 In order to control for these possible associations, demographic variables 
were treated as confounders in our analyses.  
 
Table 2 Summary of Covariates in the 23 Studies Included in the Literature Review  
Authors Screening type 
Covariates Assessed with Screening 
Family 
 History 









Mammogram x x x  x x x 
Sweetman et 
al.42 
PSA x x  x x x  
Allahverdipour 
et al.18 
Mammogram x x  x x x x 
Aro et al.19 Mammogram  x x  x x x 
Azaiza and 
Cohen40 
Mammogram x x  x x x x 
Chamot et al.20 Mammogram  x x x x   
Champion, V.28 Mammogram        
Cockburn et 
al.21 
Mammogram  x  x  x  
Dear et al.27 Colonoscopy x       
Garcia et al.13 Colonoscopy x x  x x x x 
Hassan et al.22 Mammogram x x x x    
Helzlsouer el 
al.11 
ALL TESTS        




Hughes et al.12 Colonoscopy x x  x x  x 
Lerman et al.15 Mammogram x x  x x x  
Leung et al.14 Colonoscopy  x x x x   
Lostao et al.16 Mammogram  x x x x   
Mack et al.4 Colonoscopy  x x x x x  
Madlensky et 
al.26 
Colonoscopy x x x x x   
Manjer et al.25 Mammogram x x  x x   
Palmer et al.38 Colonoscopy x x x x x   
Sutton et al.23 Mammogram  x   x   
Taylor et al.24 Mammogram x x x x x   




The data were explored descriptively using histograms for continuous variables and bar 
charts for categorical variables. Normally-distributed continuous variables were summarized as 
means and standard deviations, non-normally-distributed continuous variables as medians and 
interquartile ranges, and categorical variables as frequencies. To learn more about possible 
relationships between variables of interest in our dataset, we utilized bivariate analysis, correlation 
coefficients, and scatterplots.  
4.6.1 Modelling Approach 
Since ATP data contain three different measures for our exposure, i.e., PS (PS1-5, 
PS100gen, PS100my), and we make no a priori assumptions about the optimal measure, we first 
checked whether or not we could combine PS measures via principle components analysis (PCA). 
Specifically, PCA is a widely used statistical technique for (possibly) correlated variables into a 
set of linearly independent principal components. These principal components orthogonally 
explain the proportion of variation observed in the original set of correlated variables.60 Our goal 
with PCA was to observe if one principal component could explain the majority of the variation 




Unfortunately, the largest proportion of variance explained by one principal component was only 
67%. Therefore, PCA surrogate for PS measures was not feasible in our analyses.61-63   
After excluding PCA as a viable option for a PS surrogate with each screening test, we 
built several models – three models for each of the PS exposure measures, and one model that 
included all three PS exposures (jointly) in the model. This yielded four models for each of the 
three screening outcomes, generating a total of twelve models. To assess model fit for each 
screening outcome, we used three model fit measures – area under the receiver operating curve 
(AUC), Akaike Information Criteria (AIC), and Schwarz Criteria (SC). These fit measures helped 
assess whether examining exposure variables separately or jointly would be better suited for our 
research objectives; these results are presented in Appendix B. For each type of screening test, 
including possible confounders in the model, we observed little distinction between the three 
model fit measures, as well as parameter estimates when exposure variables were modelled 
separately compared to jointly. However, when independently modelling with each of the 
exposures, the regression coefficient estimates for the PS variables were statistically significant, 
but when modelled jointly, only PS1-5 remained statistically significant. Considering the 
similarity between the model fit measures diagnostics and a decline in statistical significance for 
the exposure variables when modelled jointly, modelling the exposures separately was preferred. 
To examine the association between PS and incident screening at follow-up, we built a 
series of logistic regression models for each of the screening tests of interest (i.e., sigmoidoscopy 
or colonoscopy [modelled as a single outcome: ‘yes’ = participant was screened with either 
sigmoidoscopy or colonoscopy; ‘no’ = participant was not screened with both sigmoidoscopy and 
colonoscopy], PSA [men only], and mammography [women only]).  All PS models controlled for 




To investigate the association between PS and incident screening (dichotomous variable 1 
= yes, 0 = no), we employed generalized linear mixed models to account for both interspecific and 
intraspecific variation and the fact participants could have either one or two separate follow-ups 
over the course of the study. Specifically, the probability of screening for the i-th participant at 
any particular follow-up time t (denoted as 	"# $  ) depended on PS (at baseline; denoted as %&#) 
and the covariates (denoted as column vector	'#($)* ). For any i-th participant: 
+,-./ "# $ = 12 + 14%&# + '#($)* 5 
where 
 	"# $ = Pr(8#
($) = 1)	for	. = 1,… , >.  
 A generalized linear mixed modelling approach (using the GLIMMIX procedure in SAS) 
was chosen due to the nature of the data and the outlined research objectives. As the outcome of 
interest (screening behaviour) is composed of multiple measurements for each individual in the 
study, and we are interested in understanding both interspecific and intraspecific variation between 
and within subjects; hence, a random intercept was included in the model along with the linear 
predictor PS at baseline.64 By including the random subject intercept in the model, we account for 
subject-specific screening behaviour over time.64 Furthermore, since our data contains missing 
values, a GLIMMIX model was deemed appropriate as under the missing at random (MAR)65 






5.1 Baseline Descriptive Statistics  
 
 ATP enrolled a total of 11,983 participants to complete the baseline (HLQ) survey. We 
excluded participants (n=10) who did not report being free of cancer at baseline (other than non-
melanoma skin cancer). HLQ was combined with Survey 2004 to create our baseline sample. We 
had excluded participants (n=75) in Survey 2004 who had not completed at least one of the three 
PS questions. Once combined (n=3,656), we excluded participants (n=746) who did not have at 
least one additional follow-up (Survey 2008 or Core/UHLQ).  With this in mind, 2,910 participants 
[49.97% males and 50.03% females] between the ages of 35 and 70 comprised the final study 
sample (see Figure 3). Of these individuals, a total of 1,452 (99.73%) females completed the 
mammography screening question, while 1,412 (97.11%) males completed the PSA screening 
question, and 2,905 (99.83%) males and females completed the sigmoidoscopy/colonoscopy 
screening question. Descriptive statistics can be found in the following three tables (Tables 3, 4, 






























As described above (Section 4.5), potential covariates were chosen based on previously 
published literature11-29,42 and theoretical importance according to the research objectives of 
interest. However, due to absence of data in ATP, we were unable to explore the predictive ability 




conditions on screening behaviour from our regression models, as complete separation occurred, 
where individuals who were not screened generally had no pre-existing conditions. Finally, 
although a priori we were uncertain about the importance of including income in the model due to 
the socialized nature of Alberta’s health system, we conducted preliminary analyses and found that 
income was not significantly associated with any type of screening behaviour. Therefore, we 
excluded income from the final models.  
  Table 3 depicts mammography screening behaviour in women with a median age of 45 
years at baseline. When assessing PS1-5, we saw that the median PS level was mid-range (3.00 
[1.00]) across both groups (screened and not screened via mammography). Furthermore, when 
examining PS100gen, median PS percentage was higher in those who were screened (40.00 
[25.00]) compared to those who were not screened (35.00 [25.00]). Comparatively, although 
behaviour trends from the medians for the PS100my remained similar across groups (30.00), the 
IQR differed between those who were screened [35.00] and those who were not screened [40.00] 
for breast cancer. Opposite from our hypothesis, the IQR for PS100my was higher between the 1st 
and 3rd quartile for women who were not screened, compared to women who were screened for 
breast cancer. 
 
Table 3 Descriptive Statistics for Mammography Screening Behaviour at Baseline [females only] 
Mammography Screening             
Characteristics 












PS1-5 (median [IQR])             
continuous  3.00 [1.00] 3.00 [1.00] 3.00 [1.00]  -1.0380 0.2993 
PS100gen (median [IQR])             
  40.00 [25.00] 40.00 [25.00] 35.00 [25.00] . -1.6240 0.1044 
PS100my (median [IQR])             
  30.00 [35.00] 30.00 [35.00] 30.00 [40.00] . -1.3159 0.1882 
Marital Status (n [%])             





As shown in Table 4, trends for the PS100my variable and PSA screening behaviour (ever 
been screened) were more in line with our hypothesis. Specifically, men who had been screened 
for prostate cancer had a higher median PS (30.00 [40.00]) compared to men who had not been 
screened via PSA (25.00 [40.00]), however this was not statistically significant (p=0.2055). For 
PS assessed using the PS1-5 and PS100gen exposure variables, medians and IQRs did not differ 
between those who were screened compared to those who were not screened.  
 
 Table 4 Descriptive Statistics for PSA Screening Behaviour at Baseline [males only] 
 
Prostate Specific Antigen (PSA) Screening                                                                                  
Characteristics 












PS1-5 (median [IQR])             
Married  1137 (78.31) 793 (54.61) 344 (23.69) 
Previously, but no longer married 196 (13.50) 145 (9.99) 51 (11.81)    
Work Status (n [%])             
Not working  203 (14.16) 147 (10.25) 56 (3.91) 36.1950 . <0.0001 
Retired  127 (8.86) 118 (8.23) 9 (0.63) 
Working part-time 372 (25.94) 248 (17.29) 124 (8.65)    
Working full-time 732 (51.05) 296 (34.59) 236 (16.46) 
Education (n [%])             
High school or less 431 (29.70) 312 (21.50) 119 (8.20) 4.3215 . 0.1152 
Post-secondary school, but not 
university 
675 (46.52) 456 (31.43) 219 (15.09) 
University or more 345 (23.78) 251 (17.30) 94 (6.48) 
Family History of Cancer (n [%])             
Yes  686 (47.25) 516 (35.54) 170 (11.71) 15.3727 . <0.0001 
No  766 (52.75) 504 (34.71) 262 (18.04) 
Area of Residence (n [%])             
Rural  423 (29.19) 271 (18.70) 152 (10.49) 10.9505 . 0.0009 
Urban  1026 (70.81) 747 (51.55) 279 (19.25) 
Age (median [IQR])             
    45.00 [11.00] 47.00 [11.00] 40.00 [7.00]   -16.6564 <0.0001 
Perceived susceptibility question 1 (PS1-5): "Compared to other people you age, what do you think are your chances of being 
diagnosed with cancer during your lifetime?", 
Perceived susceptibility question 2 (PS100gen): "On a scale of 0 %to 100%, what percentage of people your age in the general 
population do you think will be diagnosed with cancer  
in their lifetime?", 
Perceived susceptibility question 3 (PS100my): "On a scale of 0% to 100%, what would you estimate to be your chance of being 
diagnosed with cancer in your lifetime?", 




continuous 3.00 (1.00) 3.00 (1.00) 3.00 (1.00) . -0.6160 0.5379 
PS100gen (median [IQR])             
  30.00 (30.00) 30.00 (30.00) 30.00 (30.00) . 1.7121 0.0869 
PS100my (median [IQR])             
  27.00 (40.00) 30.00 (40.00) 25.00 (40.00) . 1.2661 0.2055 
Marital Status n (%)             
Never Married  141 (9.99) 25 (1.77) 116 (8.22) 16.9366 . 0.0002 
Married  1166 (82.58) 407 (28.82) 759 (53.75)   
Previously, but no longer married 105 (7.44) 37 (2.62) 68 (4.82)   
Work Status n (%)             
Not working  20 (1.43) 4 (0.29) 16 (1.14) 95.4767 . <0.0001 
Retired  123 (8.80) 83 (5.94) 40 (2.86)   
Working part-time 78 (5.58) 43 (3.08) 35 (2.50)   
Working full-time  1177 (84.19) 335 (23.96) 842 (60.23)   
Education n (%)             
High school or less  370 (26.20) 121 (8.57) 249 (17.63) 12.6635 . 0.0018 
Post-secondary school, but not 
university 
676 (47.88) 200 (14.16) 476 (33.71)   
University or more 366 (25.92) 148 (10.48) 218 (15.44   
Family History of Cancer n (%)             
Yes  645 (45.68) 256 (18.13) 389 (27.55) 22.4395 . <0.0001 
No  767 (54.32) 213 (15.08) 554 (39.24)   
Area of Residence n (%)             
Rural  371 (26.31) 117 (8.30) 254 (18.01) 0.6220 . 0.4303 
Urban  1039 (73.69) 351 (24.89) 688 (48.79)   
Age (median [IQR])               
    46.00 (14.00) 52.00 (11.00) 43.00 (10.00) . 16.3091 <0.0001 
Perceived susceptibility question 1 (PS1-5): "Compared to other people you age, what do you think are your chances of being 
diagnosed with cancer during your lifetime?", 
Perceived susceptibility question 2 (PS100gen): "On a scale of 0 %to 100%, what percentage of people your age in the general 
population do you think will be diagnosed with cancer in their lifetime?", 
Perceived susceptibility question 3 (PS100my): "On a scale of 0% to 100%, what would you estimate to be your chance of being 
diagnosed with cancer in your lifetime?", 
Interquartile Range (IQR) 
 
 
In Table 5, which assessed sigmoidoscopy/colonoscopy screening behaviour for both 
males and females, results statistically significantly differed for those who were screened 
compared to those who were not screened via sigmoidoscopy/colonoscopy for both PS100gen 
(p=0.0119) and PS100my (p<0.0001) variables. Specifically, for PS100 gen, individuals who were 
screened via sigmoidoscopy/colonoscopy had higher median PS percentage (35.00 [25.00]) 
compared to those who were not screened (30.00 [30.00]).  While for PS100my, individuals who 
were screened via sigmoidoscopy/colonoscopy had higher median PS percentage (35.00 [30.00]) 





Table 5 Descriptive Statistics for Sigmoidoscopy/Colonoscopy Screening Behaviour at Baseline [males and 
females] 
 
Sigmoidoscopy or Colonoscopy Screening                                                                                        
  
Characteristics 










 U Test 
P-value 
PS1-5 (median [IQR])             
continuous 3.00 (1.00) 3.00 (1.00) 3.00 (1.00) . 4.1261 <0.0001 
PS100gen (median [IQR])             
  33.00 (28.00) 35.00 (25.00) 30.00 (30.00) . 2.5145 0.0119 
PS100my (median [IQR])             
  30.00 (40.00) 35.00 (30.00) 25.00 (40.00) . 4.6164 <0.0001 
Marital Status (n [%])             
Never Married  264 (9.09) 47 (1.62) 217 (7.47) 0.1366 . 0.9340 
Married  2337 (80.45) 397 (13.67) 1940 (66.78)   
Previously, but no longer married 304 (10.46) 53 (1.82) 251 (8.64)   
Work Status (n [%])             
Not working  225 (7.83) 33 (1.15) 192 (6.68) 18.39 . 0.0004 
Retired  251 (8.74) 66 (2.30) 185 (6.44)   
Working part-time  453 (15.77) 83 (2.89) 370 (12.88)   
Working full-time  1944 (67.66) 309 (10.76) 1635 (56.91)   
Education (n [%])             
High school or less  807 (27.79) 150 (5.17) 657 (22.62) 4.4344 . 0.1089 
Post-secondary school, but not university 1375 (47.35) 214 (7.37) 1161 (39.98)   
University or more  722 (24.86) 133 (4.58) 589 (20.28)   
Family History of Cancer (n [%])             
Yes  1347 (46.37) 217 (7.47) 1341 (46.16) 23.96 . <0.0001 
No  1558 (53.63) 280 (9.64) 1067 (36.73)   
Area of Residence (n [%])             
Rural  808 (27.86) 140 (4.83) 668 (23.03) 0.0281 . 0.8668 
Urban  2092 (72.14) 357 (12.31) 1735 (59.83)   
Age (median [IQR])               
    45.00 (12.00) 49.00 (13.00) 45.00 (11.00) . 8.5744 <0.0001 
Perceived susceptibility question 1 (PS1-5): "Compared to other people you age, what do you think are your chances of being 
diagnosed with cancer during your lifetime?", 
Perceived susceptibility question 2 (PS100gen): "On a scale of 0 %to 100%, what percentage of people your age in the 
general population do you think will be diagnosed with cancer in their lifetime?", 
Perceived susceptibility question 3 (PS100my): "On a scale of 0% to 100%, what would you estimate to be your chance of 
being diagnosed with cancer in your lifetime?", 




5.2 Cross-sectional Results for PS variables and Screening Type 
5.2.1 Mammography Screening 
When further investigating PS variables separately for mammography screening tests using 
multivariable logistic regression models, we observed from the PS1-5 exposure variable (ordinal 
variable), that for a one-unit increase in PS of developing cancer, the odds of a female being 
screened for breast cancer (via mammography) also increased. For example, shown in Appendix B 
for PS1-5, the odds of baseline mammography were 1.24 times greater for a one-unit increase in 
PS1-5, while holding all other variables fixed (CI=1.08 – 1.42). Comparatively, for both PS100gen 
(CI=1.00 – 1.02) and PS100my (CI=1.00 – 1.02), the odds of baseline mammography were 1.01 
times greater for a one-unit increase in the respective PS measures, when holding all other variables 
fixed. However, considering both 95% confidence intervals are near 1.00, results should be 
interpreted with caution. 
5.2.2 Sigmoidoscopy/Colonoscopy Screening  
Sigmoidoscopy/colonoscopy screening behaviour, trends were similar to mammography. 
For PS1-5, the odds of being of screened versus not screened increased by 1.29 times for a one-
unit change in PS (CI=1.16 – 1.44).  
For both PS100gen and PS100my, a one-unit increase in these PS score increased the odds 
of being screened via sigmoidoscopy/colonoscopy by 1.01 (CI=1.00 – 1.02). However, similar to 
mammography screening the 95% confidence interval was near 1.00, so results should be 





After examining PSA, trends were similar to mammography and 
sigmoidoscopy/colonoscopy. Specifically, as PS increased, the odds of being screened (via PSA) 
also increased. However, this increase in the odds of being screened (via PSA) was only 
statistically significant for the PS100my variable. Furthermore, the ROC was above 70% across 
all exposure variables, which indicated suitable model fit. 
5.3 Screening Behaviour Over Time 
Due to data access restrictions, there were uncertainties of when data collection was 
completed at Time 2 (ranging from 2008 – 2015). Specifically, we were unable to obtain the date 
of survey completion for participants who completed either the Core or the UHLQ survey, which 
were administered between 2008 – 2015. As a result, we could not establish exact distance between 
time variables and could therefore not treat time as a continuous variable. With this in mind, time 
was treated as a categorical variable with levels baseline (referent category), Time 1 (T1: first 
follow-up at 1 year from baseline), and Time 2 (T2: second follow-up between 2-8 years from 
baseline). 
5.3.1 Mammography Screening Behaviour Over Time  
Table 6 depicts screening behaviour frequencies for mammography screening in women 
over time. Interestingly, at each time point, the majority of women reported being screened versus 
not screened via mammography. Specifically, at baseline, 70% of women were screened compared 
to 30% who were not screened, followed by Time 1 where 87% of women were screened and 13% 
of women were not screened, and at Time 2 where 98% of women were screened compared to 2% 




The 2% of individuals who were not screened at Time 2 created issues of small cell counts 
when conducting regression analysis. Specifically, after conducting bivariate analyses for 
mammography, creating frequency tables stratifying screening by each time point (Appendix C), 
we observed low cell counts for women who were not screened via mammography at Time 2 
(screened at 2-8 years, from 2008 – 2015) (n=19). With this in mind, issues of complete separation 
were apparent, preventing the longitudinal analysis for mammography. For example, when the 
ORs were calculated (shown in Appendix D), it was observed that small cell counts resulted in 
unreliable OR estimates that were exceptionally high.  
 
Table 6 Screening Behaviour Frequencies for Mammography Over Time (Baseline, Time 1, Time 
2) 
 
Screening Frequency via Mammography [women only] 
 
                                                                                            Surveys from ATP 
  Baseline Survey 2008 (T1) UHLQ/Core (T2) 
Screening 
Behaviour 
 (n=1452) (n=1379) (n=1021) 
Outcome (Screened yes or no (n (%))       





432   (29.75%) 184   (13.34%) 19       (1.86%) 
 
     
List of Abbreviations: ATP (Alberta’s Tomorrow Project), Baseline (Health and Lifestyle  
Questionnaire with Survey 2004), UHLQ (Updated health and Lifestyle Questionnaire), T1, T2 
(Follow up Time 1 and Time 2) 
 
5.3.2 PSA Screening Behaviour Over Time  
Table 7 depicts screening behaviour frequencies for prostate-specific antigen (PSA) 
screening tests over time. Based on this output, we can see that at baseline, almost twice as many 
participants were not screened via sigmoidoscopy/colonoscopy (67%) compared to those who 
were screened (33%). This trend changed over Time 1, as screening became split almost evenly 




sigmoidoscopy/colonoscopy. Trends in Time 2, displayed increasing frequencies in those who 
were screened (72%) compared to those who were not screened (28%) for 
sigmoidoscopy/colonoscopy. Therefore, similar to mammography screening behaviour, over time 
PSA screening behaviour increased.  
 
Table 7 Screening Behaviour Frequencies for PSA Over Time (Baseline, Time 1, Time 2) 
 
List of Abbreviations: ATP (Alberta’s Tomorrow Project), Baseline (Health and Lifestyle 
 Questionnaire with Survey 2004), UHLQ (Updated health and Lifestyle Questionnaire), T1, T2 
(Follow up Time 1 and Time 2)  
 
5.3.3 Sigmoidoscopy/Colonoscopy Screening Behaviour Over Time  
 
Table 8 depicts screening behaviour frequencies for sigmoidoscopy/colonoscopy screening 
in men and women over time. Similar to PSA, we observed that the majority of individuals were 
not screened (83%) compared to screened (17%) at baseline.  This trend is consistent across both 
Time 1 and Time 2 where 25% and 36% of individuals were screened compared to 75% and 64% 
of individuals who were not screened via sigmoidoscopy/colonoscopy, respectively. Therefore, 
similar to mammography and PSA screening behaviour, sigmoidoscopy/colonoscopy screening 
behaviour increased over time.  
Screening Frequency via PSA [men only] 
 
                                                                                                   Surveys from ATP 
  Baseline Survey 2008 
(T1) 
UHLQ/Core    (T2) 
Screening 
Behaviour 
 (n=1412) (n=1341) (n=880) 
Outcome (Screened yes or no (n (%))       
  Yes  469   (33.22%) 680   (50.71%) 635     (72.16%) 
  No  943   (66.78%) 661   (49.29%) 245     (27.84%) 





Table 8 Screening Behaviour Frequencies for Sigmoidoscopy/Colonoscopy Over Time (Baseline, 
Time 1, Time 2) 
  
Screening Frequency via Sigmoidoscopy or Colonoscopy [men and women] 
         
                                                                                      Surveys from ATP 
  Baseline Survey 2008 (T1) UHLQ /Core  (T2) 
Screening  
Behaviour 
 (n=2905) (n=2756) (n=1976) 
Outcome (Screened yes or no 
(n(%)) 
      
 Yes  497   (17.11%) 696   (25.25%) 704     (35.63%) 
 No  2408 (82.89%) 2060 (74.75%) 1272    (64.37%) 
     
List of Abbreviations: ATP (Alberta’s Tomorrow Project), Baseline (Health and Lifestyle  
Questionnaire with Survey 2004), UHLQ (Updated health and Lifestyle Questionnaire), T1, T2  
(Follow up Time 1 and Time 2) 
 
5.4 Cross-sectional Analysis for Mammography Screening [females only] 
5.4.1 – PS1-5 
Multivariable logistic regression cross-sectional results depicted in Table 9 for PS1-5 
suggested that mammography screening at baseline was statistically significantly associated with 
a female’s PS. Specifically, the adjusted odds of a female getting screened for breast cancer were 
1.24 times greater for a one-unit increase in PS1-5 (CI=1.08 – 1.42).  
5.4.2 – PS100gen 
When examining cross-sectional results between PS100gen and mammography screening 
in Table 9, PS of developing cancer was statistically significantly associated with being screened 
for breast cancer (aOR=1.01, CI=1.00 – 1.02). However, this result should be interpreted with 
caution as the odds ratio estimate for PS100gen was near 1.00, and the 95% confidence interval 




5.4.2 – PS100my 
Furthermore, the multivariable regression results for PS100my variable in Table 9 yielded 
very similar results to the aforementioned model including PS100gen. Specifically, an individual’s 
PS of developing cancer was statistically significantly associated with baseline mammography 
screening (aOR=1.01, CI=1.00 – 1.01). Furthermore, the odds ratio estimate was very close to 
1.00, and the 95% confidence interval contained 1.00. With this in mind, the results should be 
interpreted with caution.   
 
Table 9 Multivariable Logistic Regression Models (PS) for Predicting Mammography Screening     
Behaviour at Baseline   
 
Mammography Screening Behaviour by Perceived Susceptibility             
        PS1-5a,b,c PS100gend,e,f PS100myg,h,i 
Characteristics 


















Perceived Susceptibility                       
(continuous)   1.24 1.08 1.42 1.01 1.00 1.02 1.01 1.00 1.01 
Marital Status                        
Never Married   Ref Ref Ref Ref Ref Ref Ref Ref Ref 
Married   0.77 0.49 1.22 0.79 0.50 1.25 0.76 0.48 1.21 
Previously, but no longer married 0.71 0.40 1.25 0.71 0.40 1.25 0.69 0.39 1.22 
Work Status                       
Not working   Ref Ref Ref Ref Ref Ref Ref Ref Ref 
Retired   0.50 0.21 1.18 0.50 0.21 1.18 0.50 0.21 1.18 
Working part-time  0.94 0.61 1.45 0.91 0.59 1.41 0.92 0.60 1.42 
Working full-time  0.97 0.64 1.45 0.97 0.64 1.46 0.95 0.63 1.44 
Education                       
High school or less  Ref Ref Ref Ref Ref Ref Ref Ref Ref 
Post-secondary school, but not university 1.08 0.80 1.47 1.08 0.79 1.47 1.08 0.80 1.48 
University or more  1.37 0.95 1.97 1.41 0.98 2.04 1.40 0.97 2.03 
Family History of Cancer                     
No   Ref Ref Ref Ref Ref Ref Ref Ref Ref 
Yes   1.12 0.85 1.46 1.24 0.95 1.61 1.17 0.90 1.54 
Area of Residence                       
Rural   Ref Ref Ref Ref Ref Ref Ref Ref Ref 
Urban   1.82 1.37 2.42 1.81 1.36 2.41 1.75 1.32 2.34 
Age                        




ac-statistic=0.791, Bolded values are significant at a 5% level of significance 
b yes (n=1007), no (n=424), 21 missing values 
cPerceived susceptibility question 1 (PS1-5): "Compared to other people you age, what do you think are your chances of being 
diagnosed with cancer during your lifetime?" 
dc-statistic=0.789 
eyes (n=984), no (n=421), 47 missing values 
fPerceived susceptibility question 2 (PS100gen): "On a scale of 0 %to 100%, what percentage of people your age in the general 
population do you think will be diagnosed with cancer in their lifetime?" 
gc-statistic=0.789 
hyes (n=994), no (n=420), 38 missing values  
iPerceived susceptibility question 3 (PS100my): "On a scale of 0% to 100%, what would you estimate to be your chance of being 
diagnosed with cancer in your lifetime?" 
Reference group (ref)  
 
5.5 Longitudinal Logistic Regression Models 
 
 To assess how an individual’s PS of developing cancer influenced screening behaviour 
over time for PSA and sigmoidoscopy/colonoscopy, several longitudinal logistic regression 
models were implemented. Longitudinal models allowed us to preserve temporality, as well as to 
better understand whether screening behaviours were consistent across screening types.  
5.5.1 Analyses for Prostate-Specific Antigen (PSA) Screening Behaviour 
Results from Table 10, Model 1 examined the association between an individual’s PS of 
developing cancer (represented via PS1-5) to prostate-specific antigen (PSA) screening behaviour. 
Results from Model 1 indicated that the odds of being screened via PSA were 1.36 times greater 
for a one-unit increase in PS1-5 (CI=1.07 – 1.72). 
In Table 10, Model 2 examined the association between PS of developing cancer 
(represented via PS100gen) to prostate-specific antigen (PSA) screening behaviour. Results from 
Model 2 indicated that the odds of being screened via PSA were not statistically significantly 
associated with PS of developing cancer (based on the PS100gen variable).  
Results from Model 3 are depicted in Table 10 below. Model 3 examined the association 




screening behaviour. The odds of being screened via PSA were 1.02 times greater for a one-unit 
increase in PS100my (CI=1.01 – 1.03). 
 
Table 10 Longitudinal Multivariable Logistic Regression Models for Predicting PSA Screening Behaviour 
Over Time (Models 1-3) 
 
Mixed-Effects Regression Models- Prostate Specific Antigen (PSA) Screening           
                         























     
Perceived Susceptibility                        
(continuous) 1.36 1.07 1.72 1.00 0.99 1.01 1.02 1.01 1.03      
            
Time                        
Baseline (time 0) Ref Ref Ref Ref Ref Ref Ref Ref Ref      
Time 1  (follow-up 1) 7.11 5.22 9.69 7.20 5.27 9.83 7.00 5.14 9.54      
Time ≥ 2 (follow-up 2) 62.13 38.85 99.38 60.82 38.08 97.15 59.61 37.42 94.96      
Marital Status                         
Never Married Ref Ref Ref Ref Ref Ref Ref Ref Ref      
Married 2.36 1.11 5.00 2.56 1.20 5.46 2.89 1.36 6.16      
Previously, but no longer married 0.81 0.27 2.41 0.90 0.30 2.71 1.01 0.34 2.99      
Work Status                        
Not working Ref Ref Ref Ref Ref Ref Ref Ref Ref      
Retired 6.40 0.74 55.50 5.61 0.65 48.35 0.72 0.09 5.70      
Working part-time 7.64 0.85 68.86 5.95 0.67 52.87 0.98 0.12 8.00      
Working full-time 6.30 0.87 45.36 5.11 0.72 36.26 0.82 0.13 5.32      
Education                        
High school or less Ref Ref Ref Ref Ref Ref Ref Ref Ref      
Post-secondary school, but not 
university 
1.70 0.98 2.93 1.69 0.98 2.92 1.72 1.00 2.97      
University or more 3.53 1.88 6.62 3.25 1.73 6.11 3.53 1.88 6.60      
Family History of Cancer                        
No Ref Ref Ref Ref Ref Ref Ref Ref Ref      
Yes 1.46 0.92 2.30 1.63 1.04 2.55 1.47 0.93 2.31      
Area of Residence                        
Rural Ref Ref Ref Ref Ref Ref Ref Ref Ref      
Urban 1.20 0.72 1.98 1.33 0.80 2.20 1.31 0.79 2.17      
Age                         
  1.27 1.22 1.32 1.26 1.21 1.31 1.27 1.22 1.32      
a Perceived susceptibility question 1 (PS1-5): "Compared to other people you age, what do you think are your chances of 
being diagnosed with cancer during your lifetime?", 
b Perceived susceptibility question 2 (PS100gen): "On a scale of 0 %to 100%, what percentage of people your age in the 
general population do you think will be diagnosed with cancer  
in their lifetime?", 
c Perceived susceptibility question 3 (PS100my): "On a scale of 0% to 100%, what would you estimate to be your chance of 




being diagnosed with cancer in your lifetime?" 
Bolded values are significant at a 5% level of significance 
Reference group (ref) 
5.5.2 Analyses for Sigmoidoscopy/Colonoscopy Screening Behaviour  
 
 In Table 11, Model 4 examined the association between an individual’s personal PS of 
developing cancer (represented via PS1-5) to sigmoidoscopy/colonoscopy screening behaviour. 
Results from Model 4 indicated that the odds of sigmoidoscopy/colonoscopy screening were 1.97 
times greater for a one-unit increase in PS (CI=1.52 – 2.55).  
In Table 11, Model 5 examined the association between PS of developing cancer 
(represented via PS100gen) to sigmoidoscopy/colonoscopy screening behaviour. Results from 
Model 5 indicated that the odds of being screened via sigmoidoscopy/colonoscopy were not 
statistically significantly associated with PS of developing cancer (based on the PS100gen 
variable).  
In Table 11, Model 6 examined the association between PS of developing cancer 
(represented via PS100my) to sigmoidoscopy/colonoscopy screening behaviour. Results from 
Model 6 indicated that the odds of being screened via sigmoidoscopy/colonoscopy were 1.03 times 
higher for a unit increase in PS on a scale of 0 to 100 (CI=1.02 – 1.04).  
 
Table 11 Longitudinal Multivariable Logistic Regression Models for Predicting 
Sigmoidoscopy/Colonoscopy Screening Behaviour Over Time (Models 4-6) 
 
Longitudinal Logistic Regression Models for Predicting Sigmoidoscopy/Colonoscopy Screening Behaviour Over Time 
                      
    Model 4 (PS1-
5)a 
  Model 5 
(PS100gen)b 
  Model 6 
(PS100my)c 
  

















Perceived Susceptibility                        
(continuous) 1.97 1.52 2.55 1.01 1.00 1.02 1.03 1.02 1.04      
    




Time                      
Baseline (time 0) Ref Ref Ref Ref Ref Ref Ref Ref Ref    
Time 1  (follow-up 1) 4.87 3.77 6.28 4.81 3.72 6.21 4.85 3.76 6.27    
Time ≥ 2 (follow-up 2) 24.87 17.77 34.82 24.55 17.50 34.44 24.66 17.60 34.54    
Marital Status                       
Never Married Ref Ref Ref Ref Ref Ref Ref Ref Ref    
Married 1.20 0.50 2.87 1.16 0.48 2.78 1.29 0.54 3.08    
Previously, but no longer 
married 
0.97 0.32 2.95 0.90 0.29 2.76 0.93 0.31 2.83    
Work Status                      
Not working Ref Ref Ref Ref Ref Ref Ref Ref Ref    
Retired 0.94 0.28 3.13 1.17 0.34 3.96 1.04 0.31 3.48    
Working part-time 1.54 0.54 4.38 1.76 0.61 5.09 1.65 0.58 4.70    
Working full-time 1.49 0.59 3.73 1.66 0.65 4.23 1.53 0.61 3.84    
Education                      
High school or less Ref Ref Ref Ref Ref Ref Ref Ref Ref    
Post-secondary school, but 
not university 
1.04 0.58 1.84 1.06 0.59 1.89 1.06 0.59 1.89    
University or more 1.85 0.96 3.60 1.84 0.94 3.59 1.97 1.02 3.83    
Family History of Cancer                      
No Ref Ref Ref Ref Ref Ref Ref Ref Ref    
Yes 3.09 1.87 5.12 4.03 2.45 6.64 3.27 1.98 5.41    
Area of Residence                      
Rural Ref Ref Ref Ref Ref Ref Ref Ref Ref    
Urban 1.14 0.66 1.95 1.04 0.60 1.79 1.20 0.70 2.06    
Age                       
  1.21 1.17 1.26 1.20 1.15 1.24 1.21 1.16 1.26    
a Perceived susceptibility question 1 (PS1-5): "Compared to other people you age, what do you think are your chances of being 
diagnosed with cancer during your lifetime?", 
b Perceived susceptibility question 2 (PS100gen): "On a scale of 0 %to 100%, what percentage of people your age in the general 
population do you think will be diagnosed with cancer in their lifetime?", 
c Perceived susceptibility question 3 (PS100my): "On a scale of 0% to 100%, what would you estimate to be your chance of being 
diagnosed with cancer in your lifetime?" 
Bolded values are significant at a 5% level of significance 
Reference group (ref)  










6.1 PS and Screening Behaviour  
When choosing which of the three exposure variables (PS1-5, PS100gen, PS100my) best 
modelled an individual’s PS of developing cancer and screening behaviour across all screening 
tests, the similarities in fit diagnostics and model predictive abilities suggested any choice of 
exposure variable would be suitable for analysis. 
However, considering the nature of PS100gen, which evaluated general PS of those in a 
similar age group, choosing variables PS1-5 or PS100my that assessed personal PS may be 
preferred.  
6.1.1 Mammography Screening 
 
 Despite the inability to analyze the association between PS and mammography screening 
from a longitudinal perspective, our cross-sectional findings showed that a woman’s personal PS 
is associated with mammography screening behaviour. This finding is consistent with the 
theoretical framework outlined by the Health Belief Model, which suggests that screening 
behaviour is linked to one’s perception of the risk of developing cancer. This finding has also been 
reported by several additional studies from around the world, including Iran, Jordan and the United 
States, each of which assessed personal PS to mammography screening behaviour via questions 
that were adapted from the HBM.17,18,24  
 Despite our research findings, ATP contained a high proportion of women who were 
already being screened for breast cancer via mammography at baseline (70.25%). This high 




programming efforts in Alberta. Therefore, compared to other cancers, further targeted messaging 
highlighting personal PS to breast cancer may produce fewer additional mammography screenings 
because most women who will get screened have already gotten screened.  
 However, the high proportion of mammography screens was not observed for PSA and 
sigmoidoscopy/colonoscopy. With this in mind, health promotion efforts focused on PS and 
screening can be directed at other cancers, or at mammography in jurisdictions where screening 
rates are lower than in Alberta.  For example, data from the 2008 European Health Interview 
Survey (EHIS), which collected comprehensive health data from all countries in the European 
union (EU), revealed low mammography screening rates in Belgium (39%), Turkey (28%), and 
Romania (14%) for women between 50 and 69 years of age.67 Furthermore, mammography 
screening guidelines for women in the EU are comparable to those of Canada, recommending 
mammography screening every 2-3 years for women between the ages or 50-69 years.67 
6.1.2 PSA Screening 
 
 Our study findings revealed that personal PS was associated with PSA screening behaviour 
for men over time, consistent with the limited identified research available for this screening 
type.42 Specifically, only one study, by Sweetman et al.42 explored the relationship between PS 
and PSA screening behaviour. However, as discussed in Section 3.3 above, Sweetman et al.42 
enrolled a highly select sample and failed to account for potential confounders in their analysis. 
This thesis confirms the positive association between PS and PSA screening from Sweetman et 
al.42, but at the population-level using analyses adjusted for potential confounders.  
The lack of literature on PS and PSA screening behaviour underscores a need for further 
research in this area. With this in mind, our research findings revealed important insight into the 




finding not only adds to the existing literature by assessing the association between PS and PSA 
screening behaviour longitudinally in an analysis that controls for confounding, with a population-
based sample, but also provides insight that can be incorporated into PSA screening programs and 
policies required to tackle the low PSA screening rates (33%) depicted by our study findings at 
baseline. For example, current guidelines in Canada do not recommend men to be screened via 
PSA to detect prostate cancer due to potential risks associated with the test, such as false positives, 
creating an obvious barrier to PSA screening uptake.68 However, similar guidelines in the United 
States (from 2012) are in the process of being updated to reflect new evidence-based 
recommendations.69 These new recommendations suggest that doctors and patients should discuss 
the risks and benefits of the PSA test, while allowing the patient to make their own informed 
decision whether they would like to be screened or not via PSA.69 With this in mind, it may be 
more beneficial for doctor/patient discussions to emphasize the role of personal PS of developing 
cancer to highlight the patient’s PS. Nevertheless, a large barrier for PSA screening uptake in 
Canada is related to the current Canadian screening guidelines, which do not recommend screening 
via PSA.68 With this in mind, promoting personal PS of developing cancer may not be as effective 
for PSA in Canada. 
With that being said, there is a need to improve screening rates, which is further heightened 
by evidence supporting the importance of detecting prostate cancer early. Specifically, in Alberta 
there is a 100% three-year survival rate, provided diagnosis is made within the early stages of 
development (stages I to III).70 This survival rate drops to 52% when diagnosis occurs in the later 
stages of development (stage IV).70 





 Consistent with both mammography and PSA screening types, our study results reported a 
positive association between an individual’s personal PS of developing cancer and 
sigmoidoscopy/colonoscopy screening behaviour. This positive association between personal PS 
and sigmoidoscopy/colonoscopy screening behaviour was consistent with other literature,  which 
included diverse study samples from the United States, Canada, and China.4,12,14,38 Interestingly, 
the Canadian study from this literature was also conducted in Alberta, but included a sample of 
participants whose first-degree relatives were previously diagnosed with colorectal cancer.4 
Furthermore, all of the additional studies that found a positive association between PS and 
sigmoidoscopy/colonoscopy screening behaviour were limited to being cross-sectional in nature. 
Our study, however, contributes to this identified research gap by being the sole identified 
longitudinal study that included a population-based sample. Furthermore, results of this thesis 
revealed that cross-sectional findings of previously published literature, which identified a positive 
association between PS and screening behaviour, were consistent over time.  
 With this in mind, our research findings can provide insight into improving the low 
sigmoidoscopy/colonoscopy screening rates identified by our study findings (17% from 2001-
2007), which were similar to Canadian sigmoidoscopy/colonoscopy screening trends.71 
Specifically, Canadian trends reported from the Canadian Community Health Survey (2003) 
(CCHS 2003), stated that only 20.6% of Canadian respondents adhered to 
sigmoidoscopy/colonoscopy guidelines.71 Furthermore, later results from CCHS 2012 showed 
slightly better trends, yet still low, indicating that 37.2% of individuals across Canada had been 
screened using sigmoidoscopy/colonoscopy, and 36.7% in Alberta, specifically.56 Although 
recommendations for colorectal cancer screening guidelines were outlined in 2001 by the 




Canada, this increase in screening behaviour in 2012 could be related to the sizeable influx of 
additional resources (e.g., increase funding and awareness) for screening programs across all 
provinces in Canada by 2010.72 
What is problematic are the low rates of screening in this study population, especially 
considering the effectiveness of sigmoidoscopy/colonoscopy screening strategies in reducing 
incidence of colorectal cancer and mortality. A systematic review of randomized controlled trials, 
and of observational studies from Europe and the United States assessed the effectiveness of 
sigmoidoscopy/colonoscopy screening tests for the prevention of colorectal cancer incidence and 
deaths, and revealed a consistent reduction in colorectal cancer incidence and mortality rates, 
ranging from 40% to 60%, in those who were screened.73  
6.1.4 Why PS is Related to Screening Behaviour 
  To improve our understanding of how PS influences screening behaviour across screening 
types, we can draw upon the perspective of social cognition. Cognitive theories discuss the need 
for both an individual’s subjective value of an outcome and the expectation that a particular 
behaviour will achieve this valued outcome to be present, in order to exhibit a health behaviour.74 
More specifically, if the individual values the idea of not getting a specific illness, i.e., colon 
cancer, and expects that screening for colon cancer will allow them to avoid getting the disease, 
then they will undergo screening.74 The notion of expecting a successful outcome as a prompt to 
action is linked to the personal PS construct identified by the HBM.74 For example, if an 
individual’s personal PS of developing cancer is high, then they would be more likely to observe 





 Although this thesis showed the PS construct was an independent predictor of screening 
behaviour, PS is often examined in combination with other constructs, namely perceived 
severity.6,74 Together, these two constructs represent an individual’s perceived threat for 
developing a disease (e.g., cancer). Perceived threat influences health behaviour by affecting an 
individual’s subjective value regarding the importance of not getting an illness (e.g., severity 
associated with the outcome of cancer), and by contributing to their expectation that screening can 
reduce the chances of getting the undesired outcome (e.g., cancer).6,74 With that being said, future 
studies could measure both constructs (PS and perceived severity) in combination as perceived 
threat to see if together there is a stronger predictive capacity for screening behaviour, compared 
to PS on its own.   
 In summary, PS encourages screening behaviour based on social cognition concepts, such 
as self-regulation - that an individual will bring about outcomes in line with their self-perceptions 
(e.g., PS of developing cancer) and personal goals, by changing their behaviour (e.g., getting 
screened for cancer) or environment.6 With this in mind, we can help shape health promotion 
policies and interventions by better understanding why PS influences screening behaviour.  
Specifically, policies and interventions could incorporate this enhanced understanding surrounding 
how PS relates to screening behaviour, and focus on heightening an individual’s personal PS of 
developing cancer to help promote screening behaviour (see Section 6.2.3.2 for more details on 
policy implications).6 
6.2 Demographic Characteristics and Screening Behaviour 
 Demographic characteristics are identified by the HBM as factors that affect PS of 
developing cancer and in turn, health behaviour.6 With this in mind, we included additional 




published literature to influence the association between PS and screening behaviour.11-22, 24-27,29,38-
41,43 However, the adjusted relationship between PS of developing cancer and screening behaviour 
were observed over and above the effect that these additional covariates may have had on screening 
behaviour. Refer to Table 12 for a summary explanation of the proposed link between demographic 
variables, PS, and screening behaviour.  
6.2.1 Mammography  
 Personal PS was positively associated with being screened via mammography when 
analyzed cross-sectionally, while adjusting for possible confounders. Specifically, we incorporated 
six potential confounders that were outlined by previous literature as having an effect on 
mammography screening behaviour, including marital status, employment status, education, 
family history of cancer, area of residence (rural vs. urban), and age. 11-22,24-27,29,38-41,43 Not 
surprisingly, age and place of residence (rural vs. urban) were shown to have a statistically 
significant effect on mammography screening behaviour (as presented in section 5.4). This is not 
surprising as living in an urban area would facilitate access to healthcare centres that offer 
screening, and in turn, screening programming and interventions.75 Similarly (reported in section 
5.4), age was shown to have an important effect on screening behaviour. These results for age 
coincide with the influx of programming and policies targeted at high-risk groups for developing 
breast cancer, in this case middle-aged (50+).37 Furthermore, age alone could be influencing 
screening behaviour regardless of programming or targeted information. Specifically, as 
individuals progress into older age, they may become more health conscious due to their general 






6.2.2 Prostate-specific antigen (PSA) 
 Personal PS was also associated with PSA screening when adjusting for possible 
confounders and time. With only one identified study assessing the unadjusted association between 
PS and PSA screening, we included six possible confounders found to impact mammography and 
sigmoidoscopy/colonoscopy screening behaviour.15,16,19,25,38,43 Furthermore, our study included 
time as an additional variable in the model, which had only been incorporated by four studies 
assessing PS to mammography screening behaviour and therefore only examined a female study 
sample.20,21,23,25 Moreover, time across all time points was found to have a large, statistically 
significant, positive association with screening behaviour, regardless of which PS variable (PS1-
5, PS100gen, or PS100my) was included in the model. This highlights the value of assessing PS 
of developing cancer to PSA screening behaviour over time, as individuals who have been 
screened before are highly likely to be screened again in the future.77 Likewise, being married, 
having at least a university education, and age were all found to possess a strong, independent, 
positive association with screening behaviour. This was not surprising as marriage has been found 
to be linked to social control, where married people feel a sense of responsibility for others and 
therefore a heightened need and obligation to engage in their own healthy behaviours.58 While 
higher education17,22,75,78 and older age76 have been shown to be linked to having a great 
comprehension and heightened awareness of the importance of health promoting behaviours, such 
as cancer screening. Therefore, as one of the only identified longitudinal studies assessing PS to 
PSA screening, while adjusting for important confounders and screening behaviour over time, 
these results contribute to an important knowledge gap, while highlighting the positive association 






 Personal PS of developing cancer was also found to be associated with 
sigmoidoscopy/colonoscopy screening behaviour, while adjusting for possible confounders and 
the effect of time. None of the other identified studies included the effect of time on screening 
behaviour as they were all cross-sectional in nature.4,12-14,26,27,38 This is an important feature of our 
study, as the proportion of people who reported having been screened at each time point was 
greater than the previous time point for colonoscopy and sigmoidoscopy screening tests, regardless 
of which PS variable was included in the model (PS1-5, PS100gen, and PS100my). Moreover, 
having a family history of cancer was positively associated with sigmoidoscopy/colonoscopy 
screening behaviour. This statistically significant positive association between family history of 
cancer and sigmoidoscopy/colonoscopy screening behaviour was consistent with previous 
research13,26,27 and may also be related to the strong genetic linkage between family history to the 
development of colon cancer, especially in first-degree relatives of those with colon cancer.59 With 
this in mind, those with a family history of colon cancer are deemed to be at a higher risk of 
developing colon cancer than the general population, and are therefore recommended to have more 
frequent screening tests that begin at a younger age.59 
Table 12 A Summary of Proposed Explanation for the Relationship between Covariates and PS 
Variable Proposed Explanation for the Relationship to PS and Screening Behaviour 
Age • As a person ages they become more aware of their increased risk of developing 
illness.76 
• Programming efforts and guidelines are generally directed at middle-older aged 
people.37 
Marital Status • Social control: married people feel a sense of responsibility for others and therefore a 




Education • A higher education is linked to a greater comprehension and heightened awareness of 
the importance of health promoting behaviours, such as cancer screening.17,22,75,78 
Work Status • Working leads to the development of social networks, and in turn, more social contacts 
shown to be an important source for providing information about health risks.79,80,81 
• Working more leads to a greater income, which enhances access and affordability of 





• People with a family history of cancer are deemed to be at a higher risk of developing 
cancer than the general population, and are therefore recommended to have more 






• Living in an urban area would facilitate access to healthcare centres that offer 
screening, and in turn, screening programming and interventions.75 
 
6.2.4 Other Factors That May Influence PS and Screening Behaviour 
 Although the demographic characteristics outlined above were important to include due to 
their possible confounding effects on PS and screening behaviour, longitudinal results still 
revealed a positive association between PS and screening behaviour for PSA and 
sigmoidoscopy/colonoscopy tests. These results, along with concepts presented in theoretical 
frameworks, such as the HBM, suggest that other elements are influencing PS of developing 
cancer. 6 
For example, important factors to consider in the understanding of PS and health behaviour 
(e.g., screening), also proposed by the HBM, is the role of psychological characteristics such as 
personality and social pressure.6 For example, studies by Miller et al.82-85 discussed that individuals 
differ in terms of their information processing styles, which influence how they process threatening 




individuals that have a heightened attention to health threats that are of personal relevance, 
compared to low monitors who differ in attentional style and do not feel as vulnerable to health 
threats.84 Specifically, high monitors are likely to scan for and amplify threatening cues, and 
therefore may have a higher PS compared to who are not low-monitors.82-86 With this in mind, 
assessing the association between PS and screening behaviour, while controlling for psychological 
characteristics, such as personality, could offer additional insight into the relationship between 
possible modifying factors, PS and screening behaviour.  
6.3 Strengths, Limitations, and Implications 
6.3.1 Strengths 
 
 The use of ATP enabled us to explore the association between PS of developing cancer and 
screening behaviour at the population-level over time, while limiting selection bias and preserving 
temporality, compared to existing studies.  Therefore, the study design in this thesis is useful to 




As only one of ATP’s questionnaires, Survey 2004, incorporates questions surrounding PS 
to developing cancer, we were limited to measuring PS at baseline, and therefore could not assess 
how PS changed over time. Also, as the questions assessed PS of developing cancer in general, we 
could not assess PS to developing specific types of cancer. In addition, as there were three 
questions to assess PS in Survey 2004, we were limited to measuring PS with these questions. 




measure PS and the variety of different ways that exist to measure this construct (as presented in 
Table 1 Section 3.7). With this in mind, we could not be sure that we were validly measuring PS. 
However, despite the range of possibilities to measure this construct, our results were consistent 
with previously published analyses, so it was unlikely that the absence of a firm means to measure 
PS materially affected the results in our study. Furthermore, based on the receiver operating 
characteristic (ROC), the predictive abilities for the cross-sectional model assessing PS to 
sigmoidoscopy/colonoscopy screening behaviour were slightly below the 70% cut-off score for a 
model with a good fit. Moreover, due to data access restrictions, we were unable to receive 
information pertaining to the date of study completion, which prevented us from establishing the 
exact time for Time 2, which could be within a 7-year range, from 2008 – 2015. Lastly, we 
encountered issues pertaining to small cell counts for mammography when stratified by time, 
resulting in complete separation of the data, which prevented us from exploring mammography 
screening behaviour over time.  
6.3.3 Implications for Future Research and Policy Development  
6.2.3.1 Future Research 
Based on the study findings, strengths, and limitations, a breadth of opportunities exist for 
future research and policy development. Future research opportunities could include developing a 
questionnaire with more questions assessing PS as well as a scale designed to measure PS. More 
PS questions and scale items adapted from Champion, 198435 could include, “my physical health 
makes it more likely that I will get (type) cancer” or “I worry a lot about getting (type) cancer”.6 
Furthermore, the questionnaire could include a more comprehensive set of questions addressing 
additional cognitive factors outlined by the Health Belief Model (HBM), such as perceived 




Motivation Theory.6 Examples of additional questions outlined by the HBM adapted from 
Champion, 198435 for the perceived severity construct could include, “if I got (type) cancer my 
whole life would change”, while a question assessing the perceived barriers construct could 
include “it is embarrassing for me to do (screening test)”.6 In addition, the questionnaire could 
incorporate dichotomous incident screening for each type of screening test.  This will assist with 
understanding more of the causal mechanisms that may be operating to influence cancer screening 
behaviour.  
6.2.3.2 Policy Implications 
 Current findings also offer important policy implications. Across Canada, there have been 
a wide variety of screening awareness campaigns to promote screening guidelines, especially for 
colon cancer. For example, in January 2007, Ontario launched a $193.5-million five-year 
ColonCancerCheck program designed to highlight the reductions in mortality from colon cancer 
due to regular screening.88 This campaign consisted of television ads broadcasted in 22 languages, 
as well as the distribution of screening kits for individuals over the age of 50 by health care 
providers.88 Further targeted messaging, similar to the campaign discussed above, or through more 
personal means such as during a scheduled doctor’s appointment, should highlight individuals’ 
personal risk of developing colon cancer, in addition to the reduction in mortality rates by colon 
cancer in individuals who get screened. Specifically, strategies highlighting an individual’s 
personal risk of developing cancer based on factors that are relevant to the individual, such as 
family history or age, could be important when highlighting their PS level and in turn help to 
promote screening behaviour. With that in mind, creating targeted programs delivered through a 
more personalized method, such as from a family medical practice, may be a more suitable mode 




 Meanwhile, in Alberta, Alberta Health Services launched a social marketing campaign in 
2009: “Colorectal Cancer (CRC) Screening For Life” with the hope of increasing adherence to 
screening guidelines through a variety of methods such as mail packages, promotional packages 
for primary care facilities, and ads in professional publications.89 This concept of strategic social 
marketing has been useful in developing comprehensive campaigns for health promotion and 
disease and injury prevention in Canada.90 Furthermore, the social marketing approach adopted by 
Alberta Health Services is also considered a thorough way of implementing cancer prevention and 
screening campaigns.90 Interestingly, the first of eight outlined benchmark criteria for social 
marketing involves behaviour change – where the campaign focuses predominantly on changing 
the behaviour, not just raising awareness or changing attitudes.90 With this in mind, by better 
understanding the associated role of perceived personal risk of developing cancer to cancer 
screening health behaviour, this research can offer insight for achieving this first benchmark of 
behaviour change, by enhancing focus on an individual’s personal risk of developing cancer in 
marketing campaigns, and ultimately increase their PS to developing cancer.  
6.4 Conclusion 
The results reported herein were consistent with the theoretical framework outlined by the 
Health Belief Model. Specifically, screening behaviour for mammography (based on cross-
sectional analyses), as well as PSA and sigmoidoscopy/colonoscopy (based on longitudinal 
analyses), were linked to one’s perception of their risk of developing cancer.  
This relationship between PS and screening behaviour is consistent with cognitive theories, 
including the concept that an individual will exhibit a given behaviour if their subjective value of 
an outcome is in combination with their expectation that the behaviour in question will achieve 




relationship between PS and screening behaviour.  For example, self-regulation posits that an 
individual will bring about outcomes in line with their self-perceptions (e.g., PS of developing 
cancer) and personal goals, by changing their behaviour (e.g., getting screened for cancer) or 
environment.  
Demographic variables, such as age, marital status, and education were deemed factors to 
potentially confound the relationship between PS and screening behaviour, outlined by the HBM 
and previously published literature. Given the explanatory value of the HBM, additional factors in 
the HBM such as personality or social pressure, may also be influencing PS and should be explored 
in future research. 
Regardless, these study findings provide valuable insight into the role of PS and screening 
behaviour by providing a reliable study design that was population-based and measured over time. 
Not only do our reported findings add to existing literature, they also provide important policy 
implications, including the notion of highlighting personal PS to developing cancer for 
intervention-based targeted messaging, to improve screening rates in Canada.  
Furthermore, this study offers valuable insight into the association between an individual’s 
PS of developing cancer and cancer screening behaviour. The longitudinal study design, 
incorporating a population-based sample from Alberta, provides an important foundation to 
address the outlined research questions, and contributes to the current gaps in the literature 
surrounding this topic. Some of these gaps consist of evidence limited by a predominance of cross-
sectional studies, studies with limited generalizability, and studies (with one exception) that focus 
on a single cancer and a single screening test.   
In conclusion, when using data from Alberta’s Tomorrow Project (ATP), personal PS of 




associated with sigmoidoscopy/colonoscopy and prostate-specific antigen (PSA) screening tests 
when examined longitudinally. Furthermore, PS was statistically significantly associated with 
mammography screening behaviour when analyzed cross-sectionally.   
Based on these findings, future studies should further explore the role of other cognitive 
factors, such as psychological characteristics and perceived barriers, as outlined by existing social-
cognitive models, to broaden the understanding these factors have in influencing behaviour and 
behaviour change. This enhanced understanding can help inform policies and interventions 
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  PS1-5 PS100gen PS100my 
PS1-5 1.00 0.26 0.70 
PS100gen 0.26 1.00 0.51 
PS100my 0.70 0.51 1.00 
Eigenvalues of the Correlation Matrix 
  Eigenvalue Difference Proportion Cumulative 
1 2.00 1.25 0.67 0.67 
2 0.76 0.52 0.25 0.92 








Appendix C- Frequencies for Mammography Screening by Time 
Table of Time by Mammography 
Time Mammogram Frequency Percent Standard Error  Percent 
0 
Yes 1020 26.50 0.71 
No (Ref) 432 11.22 0.51 
Total 1452 37.69 0.78 
1 
Yes 1195 31.02 0.75 
No (Ref) 184 4.78 0.34 
Total 1379 35.80 0.77 
2 
Yes 1002 26.01 0.71 
No (Ref) 19 0.49 0.11 











Appendix D – Odds Ratios for Time Variables from Mammography Screening - SAS Output  
Mammography Screening Behaviour  
PS Variable  Time  OR estimate 
PS1-5 0 0 
  1 24.09 
  2 3,111.31 
PS100gen 0 0 
  1 25.95 
  2 3,383.62 
PS100my 0 0 
  1 25.77 













Appendix E - Screening via Sigmoidoscopy/Colonoscopy and PSA by Age Category According to 
Screening Guidelines  
Table of Age by Screening Behaviour for Sigmoidoscopy/Colonoscopy 
Age Screened via sigmoidoscopy/colonoscopy  
Frequency	
(Row Percent) Yes No Total 
35-49 247	 13.26) 1616	 86.74) 1863	 
50-59 145	 24.53) 446	 75.47) 591	 
60+ 59	 26.58) 163	 73.42) 222	 
Total: 451 2225 2676 
Frequency Missing = 2
29 
   
 




Screened via PSA  
Yes No Total 
35-49 170	 19.77) 690	 80.23) 860	 
50-59 182	 57.05) 137	 42.95) 319	 
60+ 79	 62.70) 47	 37.30) 126	 
Total: 431 874 1305 
Frequency Missing = 1
07 
   
 
